Home Intra-amniotic inflammation in the mid-trimester of pregnancy is a risk factor for neuropsychological disorders in childhood
Article Publicly Available

Intra-amniotic inflammation in the mid-trimester of pregnancy is a risk factor for neuropsychological disorders in childhood

  • Maria Teresa Gervasi EMAIL logo , Roberto Romero EMAIL logo , Elisa Cainelli , Paola Veronese , Maria Rosa Tran , Eunjung Jung , Manaphat Suksai , Mariachiara Bosco and Francesca Gotsch
Published/Copyright: September 29, 2022
Download Article (PDF)
Journal of Perinatal Medicine
From the journal Journal of Perinatal Medicine Volume 51 Issue 3

Abstract

Objectives

Intra-amniotic inflammation is a subclinical condition frequently caused by either microbial invasion of the amniotic cavity or sterile inflammatory stimuli, e.g., alarmins. An accumulating body of evidence supports a role for maternal immune activation in the genesis of fetal neuroinflammation and the occurrence of neurodevelopmental disorders such as cerebral palsy, schizophrenia, and autism. The objective of this study was to determine whether fetal exposure to mid-trimester intra-amniotic inflammation is associated with neurodevelopmental disorders in children eight to 12 years of age.

Methods

This is a retrospective case-control study comprising 20 children with evidence of prenatal exposure to intra-amniotic inflammation in the mid-trimester and 20 controls matched for gestational age at amniocentesis and at delivery. Amniotic fluid samples were tested for concentrations of interleukin-6 and C-X-C motif chemokine ligand 10, for bacteria by culture and molecular microbiologic methods as well as by polymerase chain reaction for eight viruses. Neuropsychological testing of children, performed by two experienced psychologists, assessed cognitive and behavioral domains. Neuropsychological dysfunction was defined as the presence of an abnormal score (<2 standard deviations) on at least two cognitive tasks.

Results

Neuropsychological dysfunction was present in 45% (9/20) of children exposed to intra-amniotic inflammation but in only 10% (2/20) of those in the control group (p=0.03). The relative risk (RR) of neuropsychological dysfunction conferred by amniotic fluid inflammation remained significant after adjusting for gestational age at delivery [aRR=4.5 (1.07–16.7)]. Of the 11 children diagnosed with neuropsychological dysfunction, nine were delivered at term and eight of them had mothers with intra-amniotic inflammation. Children exposed to intra-amniotic inflammation were found to have abnormalities in neuropsychological tasks evaluating complex skills, e.g., auditory attention, executive functions, and social skills, whereas the domains of reasoning, language, and memory were not affected in the cases and controls.

Conclusions

Asymptomatic sterile intra-amniotic inflammation in the mid-trimester of pregnancy, followed by a term birth, can still confer to the offspring a substantial risk for neurodevelopmental disorders in childhood. Early recognition and treatment of maternal immune activation in pregnancy may be a strategy for the prevention of subsequent neurodevelopmental disorders in offspring.

Keywords: amniocentesis; amniotic fluid; behavioral testing; C-X-C motif chemokine ligand 10 (CXCL-10); cognitive testing; cytokine; infection; interferon-γ-inducible protein 10 (IP-10); interleukin 6 (IL-6); neurodevelopment; neuroinflammatory

Introduction

Intra-amniotic inflammation, i.e., the presence of an inflammatory signature in the amniotic fluid, is recognized by either an excessive number of immune cells [1, 2], such as neutrophils [3], [4], [5], [6], [7], [8], [9], [10] or lymphocytes [11], [12], [13], [14], [15], [16], [17], or inflammatory cytokines [14, 18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29]. The inflammatory process can be caused by microorganisms (bacteria, viruses, fungi, and protozoa) [30], [31], [32], [33], [34] or by alarmins [35], [36], [37], [38], [39] released by host cells under conditions of stress or cell death. Intra-amniotic inflammation has been recognized in patients who have obstetrical complications such as preterm labor [1, 2, 8, 18, 30, 40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59], preterm prelabor rupture of the membranes [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], cervical insufficiency [72], [73], [74], [75], idiopathic vaginal bleeding [76], and a sonographic short cervix [77, 78]; however, in some cases, intra-amniotic inflammation is present in the absence of any complication of pregnancy and can be incidentally detected at the time of mid-trimester amniocentesis by measuring inflammatory cytokines [79].

Previous studies indicated that intra-amniotic inflammation is a heterogeneous condition and that perturbations of the cytokine network can occur in intra-amniotic infection as well as in sterile intra-amniotic inflammation [28, 80], [81], [82], [83]. In the mid-trimester of pregnancy, two subtypes of intra-amniotic inflammation have been described: one characterized by an elevation of interleukin (IL)-6 and another by an elevated concentration of C-X-C motif chemokine ligand 10 (CXCL-10), also known as interferon-γ-inducible protein 10 (IP-10) [79]. Of interest, patients with high amniotic fluid IL-6 concentrations are at risk for early preterm delivery, and their placentas typically show histological evidence of acute histologic chorioamnionitis [20, 24]. By contrast, those with elevated CXCL-10 are at risk for late spontaneous preterm delivery and show evidence of chronic placental inflammatory lesions, e.g., chronic chorioamnionitis, villitis of unknown etiology, and deciduitis of the basal plate [14, 84].

Based upon epidemiologic studies, fetal exposure to inflammation and infection during pregnancy has been implicated in the origin of mental illnesses, including cerebral palsy [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], autism spectrum disorder [102], [103], [104], [105], [106], [107], [108], [109], [110], schizophrenia [102, 103, 111], [112], [113], [114], [115], [116], [117], bipolar disorder [109], and depression [109, 118], [119], [120], [121]. A body of experimental evidence also supports the concept that infection or inflammation during pregnancy can induce fetal neuroinflammation, impair neurodevelopment, and predispose to adverse outcomes such as neurologic and mental disorders [110, 122, 123]. Although the literature sometimes refers to exposure to a maternal inflammatory response, it is likely that maternal inflammation operates through the induction of fetal neuroinflammation.

Intra-amniotic inflammation can be diagnosed as early as the mid-trimester, often occurs in the absence of a detectable clinical or subclinical maternal inflammatory response [79], and is frequently associated with delivery at term [79]. It is unknown if this condition increases the risk for adverse neurodevelopmental outcome. Therefore, the purpose of this study was to determine whether fetuses exposed to intra-amniotic inflammation in the mid-trimester of pregnancy are at risk for long-term neuropsychological disorders. We addressed this question by examining the outcomes of children whose mothers underwent a mid-trimester amniocentesis for clinical indications and in whom amniotic fluid analysis permitted a diagnosis of subclinical intra-amniotic inflammation.

Materials and methods

Study design

This retrospective nested case-control study was conducted to determine the likelihood of neurodevelopmental disorders in children exposed to intra-amniotic inflammation in the mid-trimester of pregnancy. The study is based on a cohort of 847 consecutive mothers who underwent a diagnostic mid-trimester amniocentesis for clinical indications. Exclusion criteria for this study were chromosomal anomalies and confirmed fetal anomalies. Amniotic fluid cultures for aerobic and anaerobic microorganisms, polymerase chain reaction (PCR) testing for eight viruses, white blood cell counts, IL-6 and CXCL-10 concentrations, and obstetrical outcomes of this cohort were previously reported and the specific assays for IL-6 and CXCL-10 described [79, 124].

Women had previously consented to donate samples of amniotic fluid and maternal blood for research purposes and extended their consent to the performance of neuropsychological testing in their children under a protocol approved by the Institutional Review Boards of the participating institutions (Azienda Ospedaliera Treviso, Azienda Ospedale/Universita’ Padova, Veneto Region, Italy). All patients provided written informed consent prior to the collection of samples. The hospitals have a Federal Wide Assurance with the Department of Health and Human Services of the United States.

Definition of intra-amniotic inflammation

Intra-amniotic inflammation was defined as either an IL-6 or a CXCL-10 amniotic fluid concentration above the 95th percentile of the normal values for a study population with uncomplicated pregnancies and term deliveries [79]. The cut-off values for IL-6 and CXCL-10 concentrations were 2,935 and 2,200 pg/mL, respectively. In the parent cohort, the prevalence of elevated amniotic fluid IL-6 was 6.3% (50/796) and the prevalence of elevated amniotic fluid CXCL-10 was 5.8% (45/770).

Selection of cases and controls

We selected as “cases” the children of the first 20 consecutive women with evidence of exposure to intra-amniotic inflammation in the mid-trimester according to the criteria outlined above. Twenty children of mothers without evidence of intra-amniotic inflammation, matched for gestational age at amniocentesis and at delivery (≤3 weeks), were selected as controls. Matching did not address the sex of the child. The sample size was set arbitrarily and therefore represents a sample of convenience. All amniotic fluid samples were considered negative for bacteria after testing by culture and molecular microbiologic methods (16 s broad primers). Moreover, samples were PCR-negative for eight viruses (adenoviruses, herpes simplex virus, varicella-zoster virus, human herpesvirus 6, parvovirus B19, human cytomegalovirus, enteroviruses, and Epstein-Barr virus).

Neurodevelopmental testing

Neurodevelopmental performance was assessed with a battery of tests that analyzed the cognitive and behavioral domains (Table 1). Neuropsychological testing was performed by two experienced psychologists who were masked to the results of the amniocenteses. Tests took approximately 90 min per child and involved both psychologists for each child. Neuropsychological dysfunction was defined as the presence of an abnormal score (<2 standard deviations) on at least two cognitive tasks. This approach provides dichotomous results, and it is considered useful to assess a wide range of impairments, which are then summarized in a single score. Table 1 provides a list of the neuropsychological tests [125], [126], [127], [128], [129], [130], [131], [132] and behavioral questionnaires [133], [134], [135] administered. Neuropsychological scores were transformed into age-corrected standardized scores by using published normative data.

Table 1:

The battery of tests performed to assess neuropsychological status and behavior.

Domain tested Specific instrument used for evaluation
Abstract reasoning Raven’s Coloured Progressive Matrices™ [125]
Language Naming test [126]
Attention Visual and auditory attention tests of the NEPSY-IIa [127, 128]
Memory
Short-term verbal and visual-spatial memory Digit span test [126]
Corsi block-tapping test [126]
Long-term verbal memory Word’s list [126]
List recall [126]
Executive function Phonemic verbal fluency test [126]
Tower of London test [129]
Coding test of the WISC-IV [130]
Stroop test [131]
Backward digit span test [126]
Visual-motor function Visual-motor integration test [132]
Social skills Theory of mind and emotion, a sub-test of NEPSY-IIa [127, 128]
Behavior
Child behavior checklist (CBCL) [133]
Strengths and difficulties questionnaire (SDQ) [134]
Conners’ rating scales-revised (CRS-R) [135]

  1. aA developmental NEuroPSYchological assessment. WISC-IV, Wechsler Intelligence Score for Children.

Statistical analysis

Descriptive statistics for continuous variables are displayed as medians and quartiles as well as mean and standard deviations (Table 2). Results of the neuropsychological and behavioral tests were age-corrected and converted to the following scores: z, equivalent, T, and standard as appropriate, by using published normative data [125, 126, 128], [129], [130], [131], [132]. The z score indicates the deviation from the mean population score, which is set to 0, standard deviation 1. A z score of −2 (or less) comprises 2.5% of the normal distribution and is considered significantly lower than average. Equivalent scores are a 5-point scale standardized after adjustment for age and education. An equivalent score of 0 is considered significantly lower than average. A T score indicates the deviation from the mean population score, which is set to 50, standard deviation 10. A T score of 70 (or more) is considered significantly higher than average. Scaled scores indicate the deviation from the mean population score, which is set to 10 (standard deviation 3). A scaled score of 4 (or less) is considered significantly lower than average. Scores were also converted in dichotomized outcomes (0: normal, 1: altered). Abnormal scores were those <5th percentile or 2 standard deviations. Pearson’s chi-square (X2) and Fisher’s exact tests were used for the dichotomous variable. All tests were 2-tailed, and a p-value <0.05 was considered statistically significant. Statistical analysis was performed with SPSS 20.0 (Chicago, IL). In addition, the effect of the amniotic fluid inflammation on the rate of neuropsychological dysfunction was also assessed by utilizing robust Poisson regression models and the geepack package in the R statistical language and environment (www.r-project.org).

Table 2:

Demographic, clinical, and laboratory characteristics of the study population.

Characteristics Controls (n=20) Intraamniotic inflammation (n=20) p-Value
Maternal age, years 36 (35–37.2) 35.5 (34–37) 0.262
Nulliparity 35% (n=7) 30% (n=6) 1.0
Body mass index, kg/m2 22.8 (20.9–25.3) 23.5 (21.1–25.2) 0.818
Gestational age at amniocentesis, weeks 16.7 (16.2–17.2) 16.2 (15.9–18.1) 0.416
Amniotic fluid interleukin-6, pg/mL 465.3 (362.7–1182.2) 5690.4 (4707.5–8106.4) <0.001
Amniotic fluid CXCL-10, pg/mL 616.1 (430.9–978.7) 3536.9 (2411.1–5194.3) <0.001
Maternal blood interleukin-6, pg/mL 0.69 (0.56–0.89) 0.69 (0.64–0.90) 0.23
Maternal blood CXCL-10, pg/mL 88.31 (65.4–123) 92.39 (72.1–117.1) 0.69
Gestational age at test, weeks 16.5 (16.1–17.2) 16.15 (15.6–18.1) 0.768
Gestational age at delivery, weeks 39.6 (38.1–40.3) 38.6 (37.5–39.3) 0.123
Cesarean delivery 20% (n=4) 50% (n=10) 0.096
Birthweight, grams 3377.5 (3,135–3472.5) 3,145 (2,575–3,685) 0.417
Birthweight percentile for gestational age 55 (50–75) 50 (25–75) 0.509
Small for gestational age (birthweight below 10th centile) 0% (n=0) 5% (n=1) 1.0
Male neonate 40% (n=8) 70% (n=14) 0.111
Apgar score at 1 min<7 9 (9–9) 9 (9–9) 1.0
Apgar score at 5 min<7 10 (10–10) 10 (10–10) 0.979
Duration of hospitalization of the newborn, days 3 (3–4) 3 (3–4) 0.371

  1. Data presented as median (interquartile range) and percentage (n/N); CXCL-10, C-X-C motif chemokine ligand 10.

Results

Characteristics of the study population

Demographic, clinical, and laboratory characteristics of the study population are displayed in Table 2. There were no significant differences between cases and controls for all of the examined variables except for IL-6 and CXCL-10, which, by design, were used to define cases and controls and for age at evaluation, which was solved by converting neuropsychological scores into age-correlated standardized scores by using published normative data. The adequacy of matching was evaluated with the standardized mean differences between the intra-amniotic inflammation and control groups, and there were no differences between them. Of the 20 cases with intra-amniotic inflammation, only four delivered preterm (<37 weeks of gestation). Apgar scores were above 6 in all cases and controls except for one child in the control group who was born at 28 weeks, had a birthweight of 850 g, and had Apgar scores of 2 (1 min) and 6 (5 min).

Intra-amniotic inflammation and neuropsychological dysfunction

Table 3 describes the clinical and laboratory characteristics of the women included in the study as well as pregnancy outcomes and results of neuropsychological tests of their children. Neuropsychological dysfunction was present in 45% (9/20) of children exposed to intra-amniotic inflammation but in only 10% (2/20) in the control group (p=0.03) (Table 4). Of the 11 children with neuropsychological dysfunction, nine were term deliveries, and eight of them had mothers with intra-amniotic inflammation. The relative risk (RR) of neuropsychological dysfunction conferred by amniotic fluid inflammation remained significant [aRR=4.5 (1.07–16.7)] after adjusting for gestational age at delivery. Some cognitive domains, such as reasoning, language, and memory, were not affected in the cases and controls. Neuropsychological tasks evaluating complex skills such as auditory attention, executive functions, and social skills were abnormal in children exposed to intra-amniotic inflammation.

Table 3:

Clinical and laboratory characteristics of the study participants, pregnancy outcomes, and neuropsychological tests results.

Gestational age at amniocentesis, weeks Amniotic fluid IL-6, pg/mL Amniotic fluid CXCL-10, pg/mL Spontaneous preterm labor with intact membranes or PPROM Birth weight, grams Birthweight percentile Gestational age at birth, weeks Gestational age at evaluation, years Neuropsychological index Neuropsychological domains affected
1 Case 18.2 4930.42 612.592 No 3,120 25 40 + 5 9.2 0
Control 20.3 402.671 1584.97 No 3,350 25 41 + 3 9.5 0
2 Case 16.2 841.313 9100.3 No 2,600 25 36 + 2 11.3 0
Control 16.5 125.62 366.846 No 2,800 10 41 + 0 11.5 0
3 Case 22.3 984.547 2303.03 No 3,800 75 40 + 4 9.5 0
Control 22.1 456.444 1933.06 No 3,440 50 39 + 3 10.3 0
4 Case 15.5 4855.84 447.826 No 2,300 <3 38 + 6 9.1 1 Executive and social skills, attention
Control 16.6 70.844 815.295 No 3,140 50 38 + 1 9.4 0
5 Case 15.2 6360.99 307.433 No 3,105 50 37 + 1 10.7 0
Control 15.4 482.061 652.659 No 3,120 50 38 + 1 10.8 0
6 Case 15.6 6909.96 334.995 No 980 30 28 + 0 10.7 1 Executive functions, attention
Control 17.6 172.11 534.117 No 850 25 28 + 4 8.8 0
7 Case 16.5 13142.7 1570.45 No 3,110 25 39 + 2 8.8 0
Control 16.4 421.461 1233.48 No 3,330 30 40 + 5 9.2 0
8 Case 20.2 414.103 5152.2 No 3,170 50 38 + 2 9.1 1 Executive functions, reasoning
Control 15.5 576.301 212.972 No 3,400 75 38 + 4 11.2 0
9 Case 15.6 3163.88 541.281 No 4,240 >95 39 + 2 10.4 1 Attention
Control 16.2 242.731 404.357 No 3,390 75 38 + 6 11.4 0
10 Case 15.6 439.111 4105.66 No 3,680 75 38 + 2 9.11 0
Control 15.5 425.053 538.109 No 3,300 50 39 + 5 10.9 0
11 Case 16.1 3183.68 667.341 No 3,560 75 40 + 0 10.8 0
Control 16.5 1458.75 436.925 No 3,365 75 37 + 4 10.11 0
12 Case 15.3 110.547 2413.12 No 3,270 40 39 + 0 10 1 Executive and social skills
Control 16.1 709.132 693.992 No 3,560 60 39 + 6 10.2 0
13 Case 15.6 7806.19 1057.8 No 2,610 10 39 + 1 11.2 0
Control 16.2 2287.26 518.54 No 3,480 50 40 + 4 12 0
14 Case 18 528.102 2404.89 PPROM 2,360 25 35 + 4 9 0
Control 17.1 690.765 1278.08 No 2,800 50 36 + 1 9.7 0
15 Case 16 5019.86 622.452 No 3,870 >90 38 + 0 11 1 Executive functions and attention
Control 17.3 448.5 1649.09 No 3,470 60 39 + 6 11.7 0
16 Case 15.5 9007.19 N/A No 2,410 10 37 + 4 11.3 0
Control 16.4 2605.82 376.591 No 3,860 90 40 + 3 12.2 0
17 Case 16.6 4262.65 872.118 No 3,720 75 39 + 3 10.1 0
Control 16.5 761.038 719.676 No 4,265 >90 40 + 2 10.5 0
18 Case 25.5 522.934 5320.62 No 3,700 90 39 + 3 11.2 1 Executive functions and attention
Control 20.1 1423.45 878.888 No 3,680 75 40 + 1 10.8 1 Social skills
19 Case 19.4 293.863 2968.17 Spontaneous preterm labor with intact membranes 2,500 70 34 + 0 9.6 1 Social skills, abnormal lateralization
Control 16.6 1745.63 452.248 PPROM 2000 75 31 + 6 9.4 1 Executive and social skills
20 Case 16.3 14008.8 2146.28 No 3,225 75 37 + 5 12.11 1 Executive functions
Control 16 1089.98 387.847 No 3,450 75 39 + 0 12.6 0

  1. IL-6, interleukin-6; CXCL-10, C-X-C motif chemokine ligand 10; PPROM, preterm prelabor rupture of the membranes; Neuropsychological index; 0, absence of neuropsychological dysfunction; 1, presence of neuropsychological dysfunction.

Table 4:

Frequency of neuropsychological dysfunction in children exposed and unexposed to intra-amniotic inflammation.

Neuropsychological dysfunction
Absent Present Total
Controls 18 2 20
Intra-amniotic inflammation 11 9 20
Total 29 11 40

  1. Fisher’s exact test, p=0.03; Intra-amniotic inflammation was defined as an elevated IL-6 or CXCL-10 concentration in amniotic fluid.

Of the cases with intra-amniotic inflammation, 12 (12/20) had elevated amniotic fluid IL-6 and eight (8/19) had elevated amniotic fluid CXCL-10 (Table 3). Of the cases with neuropsychological dysfunction, 5/11 had elevated amniotic fluid IL-6, 4/11 had elevated CXCL-10, and 2/11 had both IL-6 and CXCL-10 within normal range at the time of mid-trimester amniocentesis (Table 3). Of note, of the 11 children who tested positive for a neuropsychological dysfunction, nine were male, and seven were delivered by cesarean section. The outcome of behavioral testing, as reflected by interviews of the parents, showed that behavioral modifications were observed in 30% (6/20) of the cases and in 20% (4/20) of controls (p-value>0.05).

Discussion

Principal findings of the study

The main conclusion of our study is that exposure to subclinical mid-trimester intra-amniotic inflammation is a risk factor for abnormal neurodevelopmental outcomes in children 8–12 years of age and that most pregnancies affected by intra-amniotic inflammation were delivered at term.

Results in the context of what is known

Intra-amniotic inflammation is observed in 5–6% of asymptomatic patients in the mid-trimester of pregnancy, and it is a risk factor for spontaneous preterm delivery [79]. However, most patients with this condition deliver at term after a pregnancy without known complications [79, 136, 137]. Herein, we report that exposure to sterile intra-amniotic inflammation during fetal life confers risk for abnormal neurodevelopmental outcomes in childhood.

Maternal immune activation due to infection or sterile inflammation has been implicated in the genesis of neurodevelopmental disorders [110,138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151], [152], e.g., cerebral palsy [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], schizophrenia [102, 103, 111], [112], [113], [114], [115], [116], [117], depression [109, 118], [119], [120], [121], autism spectrum disorder [102], [103], [104], [105], [106], [107], [108], [109], [110], attention deficit hyperactivity disorder [110, 153], [154], [155], and Tourette syndrome [110]. Moreover, the spectrum of disorders may extend to learning disabilities [156], [157], [158] without demonstrable neurologic deficits.

The initial observations linking maternal infection and the subsequent occurrence of neurodevelopmental disorders in the offspring were made by Mednick et al. who reported that individuals diagnosed with schizophrenia were more likely to have been exposed to influenza during fetal life (ascertained by the diagnosis of maternal infection) [159]. This association was subsequently confirmed in prospective studies, and Brown et al. estimated that 14–21% of cases with schizophrenia were attributable to maternal infection [115, 160, 161]. The association was not specific to influenza and was observed with other viral infections such as rubella [162], [163], [164], [165], [166]. Since that time, a large body of epidemiological evidence has accumulated, indicating that maternal bacterial and viral infections during pregnancy can be associated with neurodevelopmental disorders [108].

Experimental studies provide strong evidence for the hypothesis that infections during pregnancy cause maternal and/or fetal immune activation, and this, in turn, can damage the developing brain [102, 142, 167], [168], [169], [170], [171], [172], [173]. During pregnancy, maternal exposure to bacterial endotoxin or lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (Poly I:C), a synthetic analog of double-stranded RNA that mimics some viral infections [172, 174, 175], can induce brain injury. These effects are mediated through an inflammatory response elicited by these microbial products and microorganisms. Further, there is evidence that fetal exposure to maternal sterile inflammation in autoimmune disorders [176], [177], [178], [179], [180], [181], [182], asthma [183], [184], [185], and obesity [186] can increase the risk of neurodevelopmental disorders.

Since maternal immune activation is associated with elevation in the concentrations of proinflammatory cytokines, these molecules have been studied and found to mediate the effects of maternal immune activation on fetal brain development [151, 161, 168, 187], [188], [189]. Specifically, IL-6 has been identified as a mediator of fetal brain injury, based on observations in pregnant mice in whom a single dose of IL-6 administered to the mother (on gestational day 12.5) led to behavioral deficits in the offspring, which can be prevented with the administration of anti-IL-6 [190]. Similar observations have been made with other cytokines [145, 172, 187, 188, 191], [192], [193], [194], [195], [196], [197], [198]. Recent studies in humans indicated a relationship between maternal IL-6 concentrations during pregnancy and neonatal functional connectivity [199], [200], [201], as assessed by magnetic resonance imaging (MRI), as well as infant cognitive development [199, 202].

Although a major emphasis has been the relationship between cytokine concentrations in the maternal compartment and neurodevelopmental outcome, it is possible and indeed likely that these effects are mediated through cytokines in the fetus. Indeed, amniotic fluid cytokine concentrations are thought to reflect fetal rather than purely maternal immune activation [203]. A series of studies using the Danish Historical Birth Cohort reported that individuals diagnosed with autism spectrum disorder had a higher mid-trimester amniotic fluid concentration of several analytes, e.g., monocyte chemoattractant protein-1 (MCP-1) [204], IL-4 [104], IL-10 [104], tumor necrosis factor-alpha (TNF-α) [104], tumor necrosis factor-beta [104], and matrix metalloproteinase-9 [205]. These observations are consistent with our report that individuals exposed to an inflammatory state during fetal life have a greater risk for abnormal neuropsychological testing in the future.

The observations in the present study are based on the results of the analysis of amniotic fluid obtained in the mid-trimester when genetic amniocenteses were performed. However, similar observations have been made between amniotic fluid concentrations of cytokines in the third trimester and the subsequent development of neurodevelopmental disorders. We reported that infants who develop white matter injury, diagnosed by ultrasound in the neonatal period, had higher amniotic fluid concentrations of IL-6, IL-1β, and TNF-α, and a subset of these infants developed cerebral palsy [86]. The same association was found between the umbilical cord concentrations of cytokines (reflecting fetal systemic inflammation) and the occurrence of white matter lesions [85]. Similar observations were reported by other investigators [93, 206], [207], [208]. Indeed, Lu et al. studied a group of patients who had an episode of premature labor and underwent amniocentesis <34 weeks of gestation. The amniotic fluid concentrations of IL-1β, IL-6, IL-8, TNF-α, granulocyte-colony stimulating factor, MCP-1, soluble intercellular adhesion molecule-1, and activin were significantly higher in cases subsequently diagnosed with brain injury by neurosonography or MRI. Similar findings were observed when examining umbilical cord blood, and this argues for the importance of fetal inflammation [209]. Indeed, there was high correlation between amniotic fluid and umbilical cord concentrations of IL-1β, IL-6, and TNF-α [209].

What is the relationship between a maternal immune response and a concentration of cytokines in amniotic fluid? Although the amniotic fluid and the maternal circulatory compartment are considered to be separate, further evidence indicated that systemic administration of LPS to pregnant rats results in an elevation in amniotic fluid concentrations of cytokines [210, 211] and also in a fetal inflammatory response, as reflected by the cytokine response in the brain as well as by changes in the fetal brain metabolome [212]. These observations are important because potential interventions aimed at maternal immune activation may target fetal inflammation and prevent brain injury. For example, the administration of N-acetyl-cysteine to pregnant rats prevents amniotic fluid [213, 214] and placental inflammation [213] and reduces cytokines in the maternal blood [213, 215], fetal blood [215, 216], and fetal brain [217]. Magnesium sulfate, currently used for neuroprotection, appears to exert its effects by downregulation of fetal inflammation [211], as demonstrated by the decrease in cytokine concentrations in the fetal brain after maternal exposure to endotoxin [218, 219]. After birth, treatment with minocycline [220], [221], [222], a microglia modulator, cyclooxygenase-2 (COX-2) inhibitors [223, 224], or N-acetyl-cysteine in dendrimers [225] can downregulate brain inflammation and improve neurologic or behavioral responses, suggesting that early treatment of neuroinflammation is possible.

Neurodevelopmental abnormalities

Among the cognitive domains, executive functions, attention, and social skills were the most affected in our cases. These high-order cognitive functions are strictly interrelated and overlapping. Executive functions have been strongly associated with academic functioning in childhood [226] and, in many cases, they are a better predictor of adult outcomes than intelligence quotient (IQ) and socio-economic-status [227]. Executive functions in childhood also predict the successful transition to kindergarten [228], school performance, and social competence in adolescence [229], and fewer drug-related problems and criminal convictions in adulthood [227]. Furthermore, abnormal social skills, attention, and executive functions are thought to be a core problem in several neurodevelopmental disorders, e.g., autism spectrum disorder [230], obsessive-compulsive disorder [231], and attention-deficit hyperactivity disorder (ADHD) [232].

These cognitive functions and some neurodevelopmental disorders, such as autism spectrum disorder, are considered disturbances of neuro-connectivity and are highly correlated to the integrity of the white matter [233], [234], [235]. The pathophysiologic mechanisms underlying white matter’s contribution to abnormal cognition and behavior are only partially understood but most probably involve the generation of reactive oxygen species that disrupt oligodendrocytes’ maturation and, ultimately, myelin formation [95, 167, 202, 236]. Given the importance of white matter in coordinating neuronal assemblies firing through myelination, even mild alterations in white matter structure may interfere with the cognitive performance [236, 237].

Clinical and research implications

The main clinical implication of this study is that a fraction of neurodevelopmental disorders appears to result from exposure to subclinical intra-amniotic inflammation in early pregnancy. The etiology, natural history, and consequences of mid-trimester intra-amniotic inflammation are unknown. Microbial invasion of the intra-amniotic cavity is a cause of intra-amniotic inflammation; however, it was not demonstrated in any of our cases. Sterile intra-amniotic inflammation has been attributed to alarmins, which are released under conditions of cellular stress [35], [36], [37], [38], [39, 71, 238]. Further work is required to determine if alarmins are elevated in the subset of patients with sterile intra-amniotic inflammation. Important clinical questions include whether it is possible to develop non-invasive methods to identify women with subclinical intra-amniotic inflammation as well as a method of treatment. Recent observations suggest that antimicrobial agents can be used to eradicate intra-amniotic inflammation even in the absence of intra-amniotic infection [239, 240].

Strengths and limitations

The strengths of this study include the ascertainment of intra-amniotic inflammation, which was objectively defined by the presence of an elevated concentration of inflammatory markers and by the performance of bacterial cultures and molecular tests to exclude bacterial infection as well as a subset of viruses. We also assessed two cytokines, IL-6, a biomarker of acute intra-amniotic inflammation, and CXCL-10, which reflects chronic inflammatory processes associated with maternal anti-fetal rejection. Another strength of this study is the long-term follow-up of children (8–12 years of age). The weakness is the limited sample size; however, this type of study is extremely difficult to conduct given that amniocentesis is less frequently performed now because of the preference for non-invasive prenatal testing for antenatal diagnosis.

Conclusions

Fetal exposure to mid-trimester intra-amniotic inflammation increases the risk of neurodevelopmental disorders even in infants born at term.

Corresponding authors: Maria Teresa Gervasi, MD, Gynaecology and Obstetrics Unit, Department of Women’s and Children’s Health, University Hospital of Padua, Padua, Italy; and Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA, E-mail: ; and Roberto Romero, MD, DMedSci, Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, and Detroit, MI, USA; Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, Michigan, USA; and Detroit Medical Center, Detroit, MI, USA, E-mail:

Funding source: Eunice Kennedy Shriver National Institute of Child Health and Human Development

Award Identifier / Grant number: HHSN275201300006C

  1. Research funding: This research was supported, in part, by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD/NIH/DHHS under Contract No. HHSN275201300006C. Dr. Romero has contributed to this work as part of his official duties as an employee of the United States Federal Government.

  2. Author contributions: All authors have accepted res-ponsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The authors state no conflicts of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Research involving human subjects complied with all relevant national regulations and institutional policies; is in accordance with the tenets of the Helsinki Declaration (as revised in 2013); and has been approved by the Institutional Review Board of the National Institute of Child Health and Human Development (NICHD), and by the Institutional Review Boards of Azienda Ospedaliera Treviso, Azienda Ospedale/Universita’ Padova, Veneto Region, Italy.

References

1. Romero, R, Quintero, R, Nores, J, Avila, C, Mazor, M, Hanaoka, S, et al.. Amniotic fluid white blood cell count: a rapid and simple test to diagnose microbial invasion of the amniotic cavity and predict preterm delivery. Am J Obstet Gynecol 1991;165:821–30. https://doi.org/10.1016/0002-9378(91)90423-o.Search in Google Scholar PubMed

2. Romero, R, Yoon, BH, Mazor, M, Gomez, R, Diamond, MP, Kenney, JS, et al.. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and Gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993;169:805–16. https://doi.org/10.1016/0002-9378(93)90009-8.Search in Google Scholar PubMed

3. Kacerovsky, M, Musilova, I, Andrys, C, Hornychova, H, Pliskova, L, Kostal, M, et al.. Prelabor rupture of membranes between 34 and 37 weeks: the intraamniotic inflammatory response and neonatal outcomes. Am J Obstet Gynecol 2014;210:325.e1–10. https://doi.org/10.1016/j.ajog.2013.10.882.Search in Google Scholar PubMed

4. Gomez-Lopez, N, Romero, R, Xu, Y, Leng, Y, Garcia-Flores, V, Miller, D, et al.. Are amniotic fluid neutrophils in women with intraamniotic infection and/or inflammation of fetal or maternal origin? Am J Obstet Gynecol 2017;217:693.e1–6. https://doi.org/10.1016/j.ajog.2017.09.013.Search in Google Scholar PubMed PubMed Central

5. Gomez-Lopez, N, Romero, R, Garcia-Flores, V, Xu, Y, Leng, Y, Alhousseini, A, et al.. Amniotic fluid neutrophils can phagocytize bacteria: a mechanism for microbial killing in the amniotic cavity. Am J Reprod Immunol 2017;78:e12723. https://doi.org/10.1111/aji.12723.Search in Google Scholar PubMed PubMed Central

6. Gomez-Lopez, N, Romero, R, Xu, Y, Miller, D, Unkel, R, Shaman, M, et al.. Neutrophil extracellular traps in the amniotic cavity of women with intra-amniotic infection: a new mechanism of host defense. Reprod Sci 2017;24:1139–53. https://doi.org/10.1177/1933719116678690.Search in Google Scholar PubMed PubMed Central

7. Martinez-Varea, A, Romero, R, Xu, Y, Miller, D, Ahmed, AI, Chaemsaithong, P, et al.. Clinical chorioamnionitis at term VII: the amniotic fluid cellular immune response. J Perinat Med 2017;45:523–38. https://doi.org/10.1515/jpm-2016-0225.Search in Google Scholar PubMed PubMed Central

8. Gomez-Lopez, N, Romero, R, Galaz, J, Xu, Y, Panaitescu, B, Slutsky, R, et al.. Cellular immune responses in amniotic fluid of women with preterm labor and intra-amniotic infection or intra-amniotic inflammation. Am J Reprod Immunol 2019;82:e13171. https://doi.org/10.1111/aji.13171.Search in Google Scholar PubMed PubMed Central

9. Galaz, J, Romero, R, Slutsky, R, Xu, Y, Motomura, K, Para, R, et al.. Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes. J Perinat Med 2020;48:222–33. https://doi.org/10.1515/jpm-2019-0395.Search in Google Scholar PubMed PubMed Central

10. Gomez-Lopez, N, Romero, R, Varrey, A, Leng, Y, Miller, D, Done, B, et al.. RNA sequencing reveals diverse functions of amniotic fluid neutrophils and monocytes/macrophages in intra-amniotic infection. J Innate Immun 2021;13:63–82. https://doi.org/10.1159/000509718.Search in Google Scholar PubMed PubMed Central

11. Gersell, DJ, Phillips, NJ, Beckerman, K. Chronic chorioamnionitis: a clinicopathologic study of 17 cases. Int J Gynecol Pathol 1991;10:217–29. https://doi.org/10.1097/00004347-199107000-00001.Search in Google Scholar

12. Gersell, DJ. Chronic villitis, chronic chorioamnionitis, and maternal floor infarction. Semin Diagn Pathol 1993;10:251–66.Search in Google Scholar

13. Jacques, SM, Qureshi, F. Chronic chorioamnionitis: a clinicopathologic and immunohistochemical study. Hum Pathol 1998;29:1457–61. https://doi.org/10.1016/s0046-8177(98)90016-8.Search in Google Scholar PubMed

14. Kim, CJ, Romero, R, Kusanovic, JP, Yoo, W, Dong, Z, Topping, V, et al.. The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth. Mod Pathol 2010;23:1000–11. https://doi.org/10.1038/modpathol.2010.73.Search in Google Scholar PubMed PubMed Central

15. Xu, Y, Tarquini, F, Romero, R, Kim, CJ, Tarca, AL, Bhatti, G, et al.. Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis. Am J Reprod Immunol 2012;67:184–97. https://doi.org/10.1111/j.1600-0897.2011.01088.x.Search in Google Scholar PubMed PubMed Central

16. Gomez-Lopez, N, Romero, R, Xu, Y, Miller, D, Leng, Y, Panaitescu, B, et al.. The immunophenotype of amniotic fluid leukocytes in normal and complicated pregnancies. Am J Reprod Immunol 2018;79:e12827. https://doi.org/10.1111/aji.12827.Search in Google Scholar PubMed PubMed Central

17. Gomez-Lopez, N, Romero, R, Xu, Y, Miller, D, Arenas-Hernandez, M, Garcia-Flores, V, et al.. Fetal T cell activation in the amniotic cavity during preterm labor: a potential mechanism for a subset of idiopathic preterm birth. J Immunol 2019;203:1793–807. https://doi.org/10.4049/jimmunol.1900621.Search in Google Scholar PubMed PubMed Central

18. Romero, R, Avila, C, Santhanam, U, Sehgal, PB. Amniotic fluid interleukin 6 in preterm labor. Association with infection. J Clin Investig 1990;85:1392–400. https://doi.org/10.1172/jci114583.Search in Google Scholar PubMed PubMed Central

19. Romero, R, Yoon, BH, Kenney, JS, Gomez, R, Allison, AC, Sehgal, PB. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am J Reprod Immunol 1993;30:167–83. https://doi.org/10.1111/j.1600-0897.1993.tb00618.x.Search in Google Scholar PubMed

20. Hillier, SL, Witkin, SS, Krohn, MA, Watts, DH, Kiviat, NB, Eschenbach, DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941–8.Search in Google Scholar

21. Coultrip, LL, Lien, JM, Gomez, R, Kapernick, P, Khoury, A, Grossman, JH. The value of amniotic fluid interleukin-6 determination in patients with preterm labor and intact membranes in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1994;171:901–11. https://doi.org/10.1016/s0002-9378(94)70057-5.Search in Google Scholar PubMed

22. Greig, PC, Herbert, WN, Robinette, BL, Teot, LA. Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 1995;173:1223–7. https://doi.org/10.1016/0002-9378(95)91358-0.Search in Google Scholar PubMed

23. Dudley, DJ, Hunter, C, Varner, MW, Mitchell, MD. Elevation of amniotic fluid interleukin-4 concentrations in women with preterm labor and chorioamnionitis. Am J Perinatol 1996;13:443–7. https://doi.org/10.1055/s-2007-994385.Search in Google Scholar PubMed

24. Baud, O, Emilie, D, Pelletier, E, Lacaze-Masmonteil, T, Zupan, V, Fernandez, H, et al.. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol 1999;106:72–7. https://doi.org/10.1111/j.1471-0528.1999.tb08088.x.Search in Google Scholar PubMed

25. Perni, SC, Vardhana, S, Korneeva, I, Tuttle, SL, Paraskevas, LR, Chasen, ST, et al.. Mycoplasma hominis and ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004;191:1382–6. https://doi.org/10.1016/j.ajog.2004.05.070.Search in Google Scholar PubMed

26. Oggé, G, Romero, R, Lee, DC, Gotsch, F, Than, NG, Lee, J, et al.. Chronic chorioamnionitis displays distinct alterations of the amniotic fluid proteome. J Pathol 2011;223:553–65. https://doi.org/10.1002/path.2825.Search in Google Scholar PubMed PubMed Central

27. Combs, CA, Gravett, M, Garite, TJ, Hickok, DE, Lapidus, J, Porreco, R, et al.. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol 2014;210:125.e1–5. https://doi.org/10.1016/j.ajog.2013.11.032.Search in Google Scholar PubMed

28. Bhatti, G, Romero, R, Rice, GE, Fitzgerald, W, Pacora, P, Gomez-Lopez, N, et al.. Compartmentalized profiling of amniotic fluid cytokines in women with preterm labor. PLoS One 2020;15:e0227881. https://doi.org/10.1371/journal.pone.0227881.Search in Google Scholar PubMed PubMed Central

29. Gershater, M, Romero, R, Arenas-Hernandez, M, Galaz, J, Motomura, K, Tao, L, et al.. IL-22 plays a dual role in the amniotic cavity: tissue injury and host defense against microbes in preterm labor. J Immunol 2022;208:1595–615. https://doi.org/10.4049/jimmunol.2100439.Search in Google Scholar PubMed PubMed Central

30. Romero, R, Sirtori, M, Oyarzun, E, Avila, C, Mazor, M, Callahan, R, et al.. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989;161:817–24. https://doi.org/10.1016/0002-9378(89)90409-2.Search in Google Scholar PubMed

31. Gibbs, RS, Romero, R, Hillier, SL, Eschenbach, DA, Sweet, RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992;166:1515–28. https://doi.org/10.1016/0002-9378(92)91628-n.Search in Google Scholar PubMed

32. Romero, R, Gomez-Lopez, N, Winters, AD, Jung, E, Shaman, M, Bieda, J, et al.. Evidence that intra-amniotic infections are often the result of an ascending invasion – a molecular microbiological study. J Perinat Med 2019;47:915–31. https://doi.org/10.1515/jpm-2019-0297.Search in Google Scholar PubMed PubMed Central

33. Winters, AD, Romero, R, Graffice, E, Gomez-Lopez, N, Jung, E, Kanninen, T, et al.. Optimization and validation of two multiplex qPCR assays for the rapid detection of microorganisms commonly invading the amniotic cavity. J Reprod Immunol 2022;149:103460. https://doi.org/10.1016/j.jri.2021.103460.Search in Google Scholar PubMed PubMed Central

34. Kacerovsky, M, Stranik, J, Matulova, J, Chalupska, M, Mls, J, Faist, T, et al.. Clinical characteristics of colonization of the amniotic cavity in women with preterm prelabor rupture of membranes, a retrospective study. Sci Rep 2022;12:5062. https://doi.org/10.1038/s41598-022-09042-x.Search in Google Scholar PubMed PubMed Central

35. Romero, R, Chaiworapongsa, T, Savasan, ZA, Xu, Y, Hussein, Y, Dong, Z, et al.. Damage-associated molecular patterns (DAMPs) in preterm labor with intact membranes and preterm PROM: a study of the alarmin HMGB1. J Matern Fetal Neonatal Med 2011;24:1444–55. https://doi.org/10.3109/14767058.2011.591460.Search in Google Scholar PubMed PubMed Central

36. Romero, R, Chaiworapongsa, T, Savasan, ZA, Hussein, Y, Dong, Z, Kusanovic, JP, et al.. Clinical chorioamnionitis is characterized by changes in the expression of the alarmin HMGB1 and one of its receptors, sRAGE. J Matern Fetal Neonatal Med 2012;25:558–67.10.3109/14767058.2011.599083Search in Google Scholar PubMed PubMed Central

37. Motomura, K, Romero, R, Garcia-Flores, V, Leng, Y, Xu, Y, Galaz, J, et al.. The alarmin interleukin-1α causes preterm birth through the NLRP3 inflammasome. Mol Hum Reprod 2020;26:712–26. https://doi.org/10.1093/molehr/gaaa054.Search in Google Scholar PubMed PubMed Central

38. Motomura, K, Romero, R, Plazyo, O, Garcia-Flores, V, Gershater, M, Galaz, J, et al.. The alarmin S100A12 causes sterile inflammation of the human chorioamniotic membranes as well as preterm birth and neonatal mortality in mice†. Biol Reprod 2021;105:1494–509. https://doi.org/10.1093/biolre/ioab188.Search in Google Scholar PubMed PubMed Central

39. Schwenkel, G, Romero, R, Slutsky, R, Motomura, K, Hsu, CD, Gomez-Lopez, N. HSP70: an alarmin that does not induce high rates of preterm birth but does cause adverse neonatal outcomes. J Matern Fetal Neonatal Med 2021;34:4110–8. https://doi.org/10.1080/14767058.2019.1706470.Search in Google Scholar PubMed PubMed Central

40. Miller, JMJr, Pupkin, MJ, Hill, GB. Bacterial colonization of amniotic fluid from intact fetal membranes. Am J Obstet Gynecol 1980;136:796–804. https://doi.org/10.1016/0002-9378(80)90458-5.Search in Google Scholar PubMed

41. Bobitt, JR, Hayslip, CC, Damato, JD. Amniotic fluid infection as determined by transabdominal amniocentesis in patients with intact membranes in premature labor. Am J Obstet Gynecol 1981;140:947–52. https://doi.org/10.1016/0002-9378(81)90090-9.Search in Google Scholar PubMed

42. Wallace, RL, Herrick, CN. Amniocentesis in the evaluation of premature labor. Obstet Gynecol 1981;57:483–6.Search in Google Scholar

43. Wahbeh, CJ, Hill, GB, Eden, RD, Gall, SA. Intra-amniotic bacterial colonization in premature labor. Am J Obstet Gynecol 1984;148:739–43. https://doi.org/10.1016/0002-9378(84)90558-1.Search in Google Scholar PubMed

44. Hameed, C, Tejani, N, Verma, UL, Archbald, F. Silent chorioamnionitis as a cause of preterm labor refractory to tocolytic therapy. Am J Obstet Gynecol 1984;149:726–30. https://doi.org/10.1016/0002-9378(84)90111-x.Search in Google Scholar PubMed

45. Leigh, J, Garite, TJ. Amniocentesis and the management of premature labor. Obstet Gynecol 1986;67:500–6.Search in Google Scholar

46. Gravett, MG, Hummel, D, Eschenbach, DA, Holmes, KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol 1986;67:229–37. https://doi.org/10.1097/00006250-198602000-00013.Search in Google Scholar PubMed

47. Romero, R, Emamian, M, Quintero, R, Wan, M, Hobbins, JC, Mazor, M, et al.. The value and limitations of the Gram stain examination in the diagnosis of intraamniotic infection. Am J Obstet Gynecol 1988;159:114–9. https://doi.org/10.1016/0002-9378(88)90503-0.Search in Google Scholar PubMed

48. Skoll, MA, Moretti, ML, Sibai, BM. The incidence of positive amniotic fluid cultures in patients preterm labor with intact membranes. Am J Obstet Gynecol 1989;161:813–6.10.1016/0020-7292(90)90507-HSearch in Google Scholar

49. Romero, R, Jimenez, C, Lohda, AK, Nores, J, Hanaoka, S, Avila, C, et al.. Amniotic fluid glucose concentration: a rapid and simple method for the detection of intraamniotic infection in preterm labor. Am J Obstet Gynecol 1990;163:968–74. https://doi.org/10.1016/0002-9378(90)91106-m.Search in Google Scholar PubMed

50. Gauthier, DW, Meyer, WJ, Bieniarz, A. Correlation of amniotic fluid glucose concentration and intraamniotic infection in patients with preterm labor or premature rupture of membranes. Am J Obstet Gynecol 1991;165:1105–10. https://doi.org/10.1016/0002-9378(91)90480-f.Search in Google Scholar PubMed

51. Coultrip, LL, Grossman, JH. Evaluation of rapid diagnostic tests in the detection of microbial invasion of the amniotic cavity. Am J Obstet Gynecol 1992;167:1231–42. https://doi.org/10.1016/s0002-9378(11)91694-9.Search in Google Scholar PubMed

52. Watts, DH, Krohn, MA, Hillier, SL, Eschenbach, DA. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992;79:351–7. https://doi.org/10.1097/00006250-199203000-00005.Search in Google Scholar PubMed

53. Gomez, R, Romero, R, Ghezzi, F, Yoon, BH, Mazor, M, Berry, SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998;179:194–202. https://doi.org/10.1016/s0002-9378(98)70272-8.Search in Google Scholar PubMed

54. Hussey, MJ, Levy, ES, Pombar, X, Meyer, P, Strassner, HT. Evaluating rapid diagnostic tests of intra-amniotic infection: gram stain, amniotic fluid glucose level, and amniotic fluid to serum glucose level ratio. Am J Obstet Gynecol 1998;179:650–6. https://doi.org/10.1016/s0002-9378(98)70059-6.Search in Google Scholar PubMed

55. Rizzo, G, Capponi, A, Vlachopoulou, A, Angelini, E, Grassi, C, Romanini, C. Ultrasonographic assessment of the uterine cervix and interleukin-8 concentrations in cervical secretions predict intrauterine infection in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol 1998;12:86–92. https://doi.org/10.1046/j.1469-0705.1998.12020086.x.Search in Google Scholar PubMed

56. Yoon, BH, Chang, JW, Romero, R. Isolation of ureaplasma urealyticum from the amniotic cavity and adverse outcome in preterm labor. Obstet Gynecol 1998;92:77–82. https://doi.org/10.1016/s0029-7844(98)00122-7.Search in Google Scholar PubMed

57. Elimian, A, Figueroa, R, Canterino, J, Verma, U, Aguero-Rosenfeld, M, Tejani, N. Amniotic fluid complement C3 as a marker of intra-amniotic infection. Obstet Gynecol 1998;92:72–6. https://doi.org/10.1016/s0029-7844(98)00123-9.Search in Google Scholar PubMed

58. Oyarzún, E, Yamamoto, M, Kato, S, Gómez, R, Lizama, L, Moenne, A. Specific detection of 16 micro-organisms in amniotic fluid by polymerase chain reaction and its correlation with preterm delivery occurrence. Am J Obstet Gynecol 1998;179:1115–9. https://doi.org/10.1016/s0002-9378(98)70115-2.Search in Google Scholar PubMed

59. Yoon, BH, Romero, R, Moon, JB, Shim, SS, Kim, M, Kim, G, et al.. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001;185:1130–6. https://doi.org/10.1067/mob.2001.117680.Search in Google Scholar PubMed

60. Garite, TJ, Freeman, RK. Chorioamnionitis in the preterm gestation. Obstet Gynecol 1982;59:539–45.Search in Google Scholar

61. Cotton, DB, Hill, LM, Strassner, HT, Platt, LD, Ledger, WJ. Use of amniocentesis in preterm gestation with ruptured membranes. Obstet Gynecol 1984;63:38–43.Search in Google Scholar

62. Zlatnik, FJ, Cruikshank, DP, Petzold, CR, Galask, RP. Amniocentesis in the identification of inapparent infection in preterm patients with premature rupture of the membranes.J Reprod Med 1984;29:656–60.Search in Google Scholar

63. Broekhuizen, FF, Gilman, M, Hamilton, PR. Amniocentesis for Gram stain and culture in preterm premature rupture of the membranes. Obstet Gynecol 1985;66:316–21.Search in Google Scholar

64. Feinstein, SJ, Vintzileos, AM, Lodeiro, JG, Campbell, WA, Weinbaum, PJ, Nochimson, DJ. Amniocentesis with premature rupture of membranes. Obstet Gynecol 1986;68:147–52.Search in Google Scholar

65. Romero, R, Emamian, M, Wan, M, Yarkoni, S, McCormack, W, Mazor, M, et al.. The value of the leukocyte esterase test in diagnosing intra-amniotic infection. Am J Perinatol 1988;5:64–9. https://doi.org/10.1055/s-2007-999657.Search in Google Scholar PubMed

66. Dudley, J, Malcolm, G, Ellwood, D. Amniocentesis in the management of preterm premature rupture of the membranes. Aust N Z J Obstet Gynaecol 1991;31:331–6. https://doi.org/10.1111/j.1479-828x.1991.tb02814.x.Search in Google Scholar PubMed

67. Romero, R, Yoon, BH, Mazor, M, Gomez, R, Gonzalez, R, Diamond, MP, et al.. A comparative study of the diagnostic performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 1993;169:839–51. https://doi.org/10.1016/0002-9378(93)90014-a.Search in Google Scholar PubMed

68. Yoon, BH, Jun, JK, Park, KH, Syn, HC, Gomez, R, Romero, R. Serum C-reactive protein, white blood cell count, and amniotic fluid white blood cell count in women with preterm premature rupture of membranes. Obstet Gynecol 1996;88:1034–40. https://doi.org/10.1016/s0029-7844(96)00339-0.Search in Google Scholar PubMed

69. Blackwell, SC, Berry, SM. Role of amniocentesis for the diagnosis of subclinical intra-amniotic infection in preterm premature rupture of the membranes. Curr Opin Obstet Gynecol 1999;11:541–7. https://doi.org/10.1097/00001703-199912000-00001.Search in Google Scholar PubMed

70. Shim, SS, Romero, R, Hong, JS, Park, CW, Jun, JK, Kim, BI, et al.. Clinical significance of intra-amniotic inflammation in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 2004;191:1339–45. https://doi.org/10.1016/j.ajog.2004.06.085.Search in Google Scholar PubMed

71. Romero, R, Miranda, J, Chaemsaithong, P, Chaiworapongsa, T, Kusanovic, JP, Dong, Z, et al.. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med 2015;28:1394–409. https://doi.org/10.3109/14767058.2014.958463.Search in Google Scholar PubMed PubMed Central

72. Romero, R, Gonzalez, R, Sepulveda, W, Brandt, F, Ramirez, M, Sorokin, Y, et al.. Infection and labor. VIII. Microbial invasion of the amniotic cavity in patients with suspected cervical incompetence: prevalence and clinical significance. Am J Obstet Gynecol 1992;167:1086–91. https://doi.org/10.1016/s0002-9378(12)80043-3.Search in Google Scholar PubMed

73. Mays, JK, Figueroa, R, Shah, J, Khakoo, H, Kaminsky, S, Tejani, N. Amniocentesis for selection before rescue cerclage. Obstet Gynecol 2000;95:652–5. https://doi.org/10.1016/s0029-7844(99)00633-x.Search in Google Scholar PubMed

74. Lee, SE, Romero, R, Park, CW, Jun, JK, Yoon, BH. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol 2008;198:633.e1–8. https://doi.org/10.1016/j.ajog.2007.11.047.Search in Google Scholar PubMed

75. Bujold, E, Morency, AM, Rallu, F, Ferland, S, Tétu, A, Duperron, L, et al.. Bacteriology of amniotic fluid in women with suspected cervical insufficiency. J Obstet Gynaecol Can 2008;30:882–7. https://doi.org/10.1016/s1701-2163(16)32967-x.Search in Google Scholar

76. Gómez, R, Romero, R, Nien, JK, Medina, L, Carstens, M, Kim, YM, et al.. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med: Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies 2005;18:31–7.https://doi.org/10.1080/14767050500217863.Search in Google Scholar PubMed

77. Hassan, S, Romero, R, Hendler, I, Gomez, R, Khalek, N, Espinoza, J, et al.. A sonographic short cervix as the only clinical manifestation of intra-amniotic infection. J Perinat Med 2006;34:13–9. https://doi.org/10.1515/jpm.2006.002.Search in Google Scholar PubMed PubMed Central

78. Romero, R, Miranda, J, Chaiworapongsa, T, Chaemsaithong, P, Gotsch, F, Dong, Z, et al.. Sterile intra-amniotic inflammation in asymptomatic patients with a sonographic short cervix: prevalence and clinical significance. J Matern Fetal Neonatal Med 2015;28:1343–59. https://doi.org/10.3109/14767058.2014.954243.Search in Google Scholar PubMed PubMed Central

79. Gervasi, MT, Romero, R, Bracalente, G, Erez, O, Dong, Z, Hassan, SS, et al.. Midtrimester amniotic fluid concentrations of interleukin-6 and interferon-gamma-inducible protein-10: evidence for heterogeneity of intra-amniotic inflammation and associations with spontaneous early (<32 weeks) and late (>32 weeks) preterm delivery. J Perinat Med 2012;40:329–43. https://doi.org/10.1515/jpm-2012-0034.Search in Google Scholar PubMed PubMed Central

80. Keelan, JA, Wang, K, Chaiworapongsa, T, Romero, R, Mitchell, MD, Sato, TA, et al.. Macrophage inhibitory cytokine 1 in fetal membranes and amniotic fluid from pregnancies with and without preterm labour and premature rupture of membranes. Mol Hum Reprod 2003;9:535–40. https://doi.org/10.1093/molehr/gag068.Search in Google Scholar PubMed

81. Romero, R, Erez, O, Espinoza, J. Intrauterine infection, preterm labor, and cytokines. J Soc Gynecol Invest 2005;12:463–5. https://doi.org/10.1016/j.jsgi.2005.09.001.Search in Google Scholar PubMed

82. Romero, R, Grivel, JC, Tarca, AL, Chaemsaithong, P, Xu, Z, Fitzgerald, W, et al.. Evidence of perturbations of the cytokine network in preterm labor. Am J Obstet Gynecol 2015;213:836 e1–8. https://doi.org/10.1016/j.ajog.2015.07.037.Search in Google Scholar PubMed PubMed Central

83. Tarca, AL, Fitzgerald, W, Chaemsaithong, P, Xu, Z, Hassan, SS, Grivel, JC, et al.. The cytokine network in women with an asymptomatic short cervix and the risk of preterm delivery. Am J Reprod Immunol 2017;78:e12686. https://doi.org/10.1111/aji.12686.Search in Google Scholar PubMed PubMed Central

84. Kim, MJ, Romero, R, Kim, CJ, Tarca, AL, Chhauy, S, LaJeunesse, C, et al.. Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease. J Immunol 2009;182:3919–27. https://doi.org/10.4049/jimmunol.0803834.Search in Google Scholar PubMed PubMed Central

85. Yoon, BH, Romero, R, Yang, SH, Jun, JK, Kim, IO, Choi, JH, et al.. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996;174:1433–40. https://doi.org/10.1016/s0002-9378(96)70585-9.Search in Google Scholar PubMed

86. Yoon, BH, Jun, JK, Romero, R, Park, KH, Gomez, R, Choi, JH, et al.. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997;177:19–26. https://doi.org/10.1016/s0002-9378(97)70432-0.Search in Google Scholar PubMed

87. Grether, JK, Nelson, KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997;278:207–11. https://doi.org/10.1001/jama.1997.03550030047032.Search in Google Scholar

88. Dammann, O, Leviton, A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997;42:1–8. https://doi.org/10.1203/00006450-199707000-00001.Search in Google Scholar PubMed

89. Sävman, K, Blennow, M, Gustafson, K, Tarkowski, E, Hagberg, H. Cytokine response in cerebrospinal fluid after birth asphyxia. Pediatr Res 1998;43:746–51. https://doi.org/10.1203/00006450-199806000-00006.Search in Google Scholar PubMed

90. Nelson, KB, Dambrosia, JM, Grether, JK, Phillips, TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998;44:665–75. https://doi.org/10.1002/ana.410440413.Search in Google Scholar PubMed

91. Yoon, BH, Romero, R, Park, JS, Kim, CJ, Kim, SH, Choi, JH, et al.. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;182:675–81. https://doi.org/10.1067/mob.2000.104207.Search in Google Scholar PubMed

92. Wu, YW, Colford, JMJr. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA 2000;284:1417–24. https://doi.org/10.1001/jama.284.11.1417.Search in Google Scholar PubMed

93. Dammann, O, Leviton, A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 2000;12:99–104. https://doi.org/10.1097/00008480-200004000-00002.Search in Google Scholar PubMed

94. Moon, JB, Kim, JC, Yoon, BH, Romero, R, Kim, G, Oh, SY, et al.. Amniotic fluid matrix metalloproteinase-8 and the development of cerebral palsy. J Perinat Med 2002;30:301–6. https://doi.org/10.1515/jpm.2002.044.Search in Google Scholar PubMed

95. Leviton, A, Dammann, O. Coagulation, inflammation, and the risk of neonatal white matter damage. Pediatr Res 2004;55:541–5. https://doi.org/10.1203/01.pdr.0000121197.24154.82.Search in Google Scholar PubMed

96. Jacobsson, B, Hagberg, G. Antenatal risk factors for cerebral palsy. Best Pract Res Clin Obstet Gynaecol 2004;18:425–36. https://doi.org/10.1016/j.bpobgyn.2004.02.011.Search in Google Scholar PubMed

97. Bartha, AI, Foster-Barber, A, Miller, SP, Vigneron, DB, Glidden, DV, Barkovich, AJ, et al.. Neonatal encephalopathy: association of cytokines with MR spectroscopy and outcome. Pediatr Res 2004;56:960–6. https://doi.org/10.1203/01.pdr.0000144819.45689.bb.Search in Google Scholar PubMed

98. Hagberg, H, Mallard, C, Jacobsson, B. Role of cytokines in preterm labour and brain injury. BJOG An Int J Obstet Gynaecol 2005;112:16–8. https://doi.org/10.1111/j.1471-0528.2005.00578.x.Search in Google Scholar PubMed

99. Leviton, A, Allred, EN, Kuban, KC, Hecht, JL, Onderdonk, AB, O’Shea, TM, et al.. Microbiologic and histologic characteristics of the extremely preterm infant’s placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res 2010;67:95–101. https://doi.org/10.1203/pdr.0b013e3181bf5fab.Search in Google Scholar PubMed PubMed Central

100. Fleiss, B, Gressens, P. Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 2012;11:556–66. https://doi.org/10.1016/s1474-4422(12)70058-3.Search in Google Scholar

101. Lawrence, SM, Wynn, JL. Chorioamnionitis, IL-17A, and fetal origins of neurologic disease. Am J Reprod Immunol 79:2018:e12803. https://doi.org/10.1111/aji.12803.Search in Google Scholar PubMed PubMed Central

102. Patterson, PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009;204:313–21. https://doi.org/10.1016/j.bbr.2008.12.016.Search in Google Scholar PubMed

103. Meyer, U, Feldon, J, Dammann, O. Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res 2011;69:26r–33r. https://doi.org/10.1203/pdr.0b013e318212c196.Search in Google Scholar PubMed PubMed Central

104. Abdallah, MW, Larsen, N, Grove, J, Nørgaard-Pedersen, B, Thorsen, P, Mortensen, EL, et al.. Amniotic fluid inflammatory cytokines: potential markers of immunologic dysfunction in autism spectrum disorders. World J Biol Psychiatry 2013;14:528–38. https://doi.org/10.3109/15622975.2011.639803.Search in Google Scholar PubMed

105. Zerbo, O, Iosif, AM, Walker, C, Ozonoff, S, Hansen, RL, Hertz-Picciotto, I. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood autism risks from genetics and environment) study. J Autism Dev Disord 2013;43:25–33. https://doi.org/10.1007/s10803-012-1540-x.Search in Google Scholar PubMed PubMed Central

106. Lee, BK, Magnusson, C, Gardner, RM, Blomström, Å, Newschaffer, CJ, Burstyn, I, et al.. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun 2015;44:100–5. https://doi.org/10.1016/j.bbi.2014.09.001.Search in Google Scholar PubMed PubMed Central

107. Madore, C, Leyrolle, Q, Lacabanne, C, Benmamar-Badel, A, Joffre, C, Nadjar, A, et al.. Neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plast 2016;2016:3597209.10.1155/2016/3597209Search in Google Scholar PubMed PubMed Central

108. Jiang, HY, Xu, LL, Shao, L, Xia, RM, Yu, ZH, Ling, ZX, et al.. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun 2016;58:165–72. https://doi.org/10.1016/j.bbi.2016.06.005.Search in Google Scholar PubMed

109. al-Haddad, BJS, Jacobsson, B, Chabra, S, Modzelewska, D, Olson, EM, Bernier, R, et al.. Long-term risk of neuropsychiatric disease after exposure to infection in utero. JAMA Psychiatr 2019;76:594–602.10.1001/jamapsychiatry.2019.0029Search in Google Scholar PubMed PubMed Central

110. Han, VX, Patel, S, Jones, HF, Nielsen, TC, Mohammad, SS, Hofer, MJ, et al.. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl Psychiatry 2021;11:71. https://doi.org/10.1038/s41398-021-01198-w.Search in Google Scholar PubMed PubMed Central

111. Brown, AS, Susser, ES. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 2002;8:51–7. https://doi.org/10.1002/mrdd.10004.Search in Google Scholar PubMed

112. Gilmore, JH, Fredrik Jarskog, L, Vadlamudi, S, Lauder, JM. Prenatal infection and risk for schizophrenia: IL-1beta, IL-6, and TNFalpha inhibit cortical neuron dendrite development. Neuropsychopharmacology 2004;29:1221–9. https://doi.org/10.1038/sj.npp.1300446.Search in Google Scholar PubMed

113. Nawa, H, Takei, N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 2006;56:2–13. https://doi.org/10.1016/j.neures.2006.06.002.Search in Google Scholar PubMed

114. Brown, AS, Vinogradov, S, Kremen, WS, Poole, JH, Deicken, RF, Penner, JD, et al.. Prenatal exposure to maternal infection and executive dysfunction in adult schizophrenia. Am J Psychiatr 2009;166:683–90. https://doi.org/10.1176/appi.ajp.2008.08010089.Search in Google Scholar PubMed PubMed Central

115. Brown, AS, Derkits, EJ. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatr 2010;167:261–80. https://doi.org/10.1176/appi.ajp.2009.09030361.Search in Google Scholar PubMed PubMed Central

116. Aguilar-Valles, A, Rodrigue, B, Matta-Camacho, E. Maternal immune activation and the development of dopaminergic neurotransmission of the offspring: relevance for schizophrenia and other psychoses. Front Psychiatr 2020;11:852. https://doi.org/10.3389/fpsyt.2020.00852.Search in Google Scholar PubMed PubMed Central

117. Mongan, D, Ramesar, M, Föcking, M, Cannon, M, Cotter, D. Role of inflammation in the pathogenesis of schizophrenia: a review of the evidence, proposed mechanisms and implications for treatment. Early Interv Psychiatry 2020;14:385–97. https://doi.org/10.1111/eip.12859.Search in Google Scholar PubMed

118. Khan, D, Fernando, P, Cicvaric, A, Berger, A, Pollak, A, Monje, FJ, et al.. Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry 2014;4:e363. https://doi.org/10.1038/tp.2013.132.Search in Google Scholar PubMed PubMed Central

119. Majidi-Zolbanin, J, Doosti, MH, Kosari-Nasab, M, Salari, AA. Prenatal maternal immune activation increases anxiety- and depressive-like behaviors in offspring with experimental autoimmune encephalomyelitis. Neuroscience 2015;294:69–81. https://doi.org/10.1016/j.neuroscience.2015.03.016.Search in Google Scholar PubMed

120. Depino, AM. Early prenatal exposure to LPS results in anxiety- and depression-related behaviors in adulthood. Neuroscience 2015;299:56–65. https://doi.org/10.1016/j.neuroscience.2015.04.065.Search in Google Scholar PubMed

121. Ronovsky, M, Berger, S, Zambon, A, Reisinger, SN, Horvath, O, Pollak, A, et al.. Maternal immune activation transgenerationally modulates maternal care and offspring depression-like behavior. Brain Behav Immun 2017;63:127–36. https://doi.org/10.1016/j.bbi.2016.10.016.Search in Google Scholar PubMed

122. Jin, C, Londono, I, Mallard, C, Lodygensky, GA. New means to assess neonatal inflammatory brain injury. J Neuroinflammation 2015;12:180. https://doi.org/10.1186/s12974-015-0397-2.Search in Google Scholar PubMed PubMed Central

123. Han, VX, Patel, S, Jones, HF, Dale, RC. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat Rev Neurol 2021;17:564–79. https://doi.org/10.1038/s41582-021-00530-8.Search in Google Scholar PubMed

124. Gervasi, MT, Romero, R, Bracalente, G, Chaiworapongsa, T, Erez, O, Dong, Z, et al.. Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. J Matern Fetal Neonatal Med 2012;25:2002–13. https://doi.org/10.3109/14767058.2012.683899.Search in Google Scholar PubMed PubMed Central

125. Raven, JC, Court, JH, Raven, J. Manual for raven’s progressive matrices. Oxford, UK: Oxford Psychologists Press; 1992.Search in Google Scholar

126. Bisiacchi, PS, Cendron, M, Gugliotta, M, Tressoldi, P, Vio, C. Batteria di valutazione neuropsicologica per l’età evolutiva. Centro studi Erickson Trento; 2005.Search in Google Scholar

127. Korkman, M, Kirk, U, Kemp, S. NEPSY-II: a developmental neuropsychological assessment, 2nd ed. San Antonio, TX: Psychological Corporation; 2007.Search in Google Scholar

128. Urgesi, C, Campanella, F, Fabbro, F. NEPSY-II. In: Second Edition contributo alla taratura italiana firenze: Giunti OS Organizzazioni Speciali; 2011.Search in Google Scholar

129. Facello, GS, Vio, C, Cianchetti, C. TOL torre di Londra, test ti valutazione delle funzioni esecutive (pianificazione e problem solving). Trento, Italy: Erickson; 2006.Search in Google Scholar

130. Orsini, A, Pezzuti, L, Picone, L. WISC-IV. Contributo alla taratura italiana. Firenze: Giunti OS Organizzazioni Speciali; 2012.Search in Google Scholar

131. Marzocchi, GM, Re, A, Cornoldi, C. BIA - Batteria italiana per l’ADHD per la valutazione dei bambini con deficit di attenzione/iperattività. Trento: Erickson; 2010.Search in Google Scholar

132. Beery, KE, Beery, NA. The Beery-Buktenica developmental test of visual motor integration: administration, scoring, and teaching manual, 5th ed. Cleveland, OH: Modern Curriculum Press; 2004.Search in Google Scholar

133. Achenbach, TM, Rescorla, L. Manual for the ASEBA school-age forms & profiles: an integrated system of multi-informant assessment. Burlington, VTYouth, &Families: University of Vermont, Research Center for Children; 2001.Search in Google Scholar

134. Goodman, R, Meltzer, H, Bailey, V. The strengths and difficulties questionnaire: a pilot study on the validity of the self-report version. Eur Child Adolesc Psychiatry 1998;7:125–30. https://doi.org/10.1007/s007870050057.Search in Google Scholar PubMed

135. CK, C. Conners’ rating scales-revised. New York: Multi-Health Systems; 2000.Search in Google Scholar

136. Malamitsi-Puchner, A, Vrachnis, N, Samoli, E, Baka, S, Iliodromiti, Z, Puchner, KP, et al.. Possible early prediction of preterm birth by determination of novel proinflammatory factors in midtrimester amniotic fluid. Ann N Y Acad Sci 2006;1092:440–9. https://doi.org/10.1196/annals.1365.043.Search in Google Scholar PubMed

137. Puchner, K, Iavazzo, C, Gourgiotis, D, Boutsikou, M, Baka, S, Hassiakos, D, et al.. Mid-trimester amniotic fluid interleukins (IL-1β, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 2011;25:141–8.Search in Google Scholar

138. Garbett, KA, Hsiao, EY, Kálmán, S, Patterson, PH, Mirnics, K. Effects of maternal immune activation on gene expression patterns in the fetal brain. Transl Psychiatry 2012;2:e98. https://doi.org/10.1038/tp.2012.24.Search in Google Scholar PubMed PubMed Central

139. Hagberg, H, Gressens, P, Mallard, C. Inflammation during fetal and neonatal life: implications for neurologic and neuropsychiatric disease in children and adults. Ann Neurol 2012;71:444–57. https://doi.org/10.1002/ana.22620.Search in Google Scholar PubMed

140. Knuesel, I, Chicha, L, Britschgi, M, Schobel, SA, Bodmer, M, Hellings, JA, et al.. Maternal immune activation and abnormal brain development across CNS disorders. Nat Rev Neurol 2014;10:643–60. https://doi.org/10.1038/nrneurol.2014.187.Search in Google Scholar PubMed

141. Van Steenwinckel, J, Schang, AL, Sigaut, S, Chhor, V, Degos, V, Hagberg, H, et al.. Brain damage of the preterm infant: new insights into the role of inflammation. Biochem Soc Trans 2014;42:557–63. https://doi.org/10.1042/bst20130284.Search in Google Scholar

142. Bauman, MD, Iosif, AM, Smith, SE, Bregere, C, Amaral, DG, Patterson, PH. Activation of the maternal immune system during pregnancy alters behavioral development of rhesus monkey offspring. Biol Psychiatr 2014;75:332–41. https://doi.org/10.1016/j.biopsych.2013.06.025.Search in Google Scholar PubMed PubMed Central

143. Hagberg, H, Mallard, C, Ferriero, DM, Vannucci, SJ, Levison, SW, Vexler, ZS, et al.. The role of inflammation in perinatal brain injury. Nat Rev Neurol 2015;11:192–208. https://doi.org/10.1038/nrneurol.2015.13.Search in Google Scholar PubMed PubMed Central

144. Armstrong-Wells, J, Donnelly, M, Post, MD, Manco-Johnson, MJ, Winn, VD, Sébire, G. Inflammatory predictors of neurologic disability after preterm premature rupture of membranes. Am J Obstet Gynecol 2015;212:212.e1–9. https://doi.org/10.1016/j.ajog.2014.09.016.Search in Google Scholar PubMed PubMed Central

145. Estes, ML, McAllister, AK. Maternal immune activation: implications for neuropsychiatric disorders. Science 2016;353:772–7. https://doi.org/10.1126/science.aag3194.Search in Google Scholar PubMed PubMed Central

146. Boulanger-Bertolus, J, Pancaro, C, Mashour, GA. Increasing role of maternal immune activation in neurodevelopmental disorders. Front Behav Neurosci 2018;12:230. https://doi.org/10.3389/fnbeh.2018.00230.Search in Google Scholar PubMed PubMed Central

147. Gumusoglu, SB, Stevens, HE. Maternal inflammation and neurodevelopmental programming: a review of preclinical outcomes and implications for translational psychiatry. Biol Psychiatr 2019;85:107–21. https://doi.org/10.1016/j.biopsych.2018.08.008.Search in Google Scholar PubMed

148. Al-Haddad, BJS, Oler, E, Armistead, B, Elsayed, NA, Weinberger, DR, Bernier, R, et al.. The fetal origins of mental illness. Am J Obstet Gynecol 2019;221:549–62. https://doi.org/10.1016/j.ajog.2019.06.013.Search in Google Scholar PubMed PubMed Central

149. Furman, D, Campisi, J, Verdin, E, Carrera-Bastos, P, Targ, S, Franceschi, C, et al.. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019;25:1822–32. https://doi.org/10.1038/s41591-019-0675-0.Search in Google Scholar PubMed PubMed Central

150. Prieto-Villalobos, J, Alvear, TF, Liberona, A, Lucero, CM, Martínez-Araya, CJ, Balmazabal, J, et al.. Astroglial hemichannels and pannexons: the hidden link between maternal inflammation and neurological disorders. Int J Mol Sci 2021;22:9503. https://doi.org/10.3390/ijms22179503.Search in Google Scholar PubMed PubMed Central

151. Zawadzka, A, Cieślik, M, Adamczyk, A. The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment. Int J Mol Sci 2021;22. https://doi.org/10.3390/ijms222111516.Search in Google Scholar PubMed PubMed Central

152. Kwon, HK, Choi, GB, Huh, JR. Maternal inflammation and its ramifications on fetal neurodevelopment. Trends Immunol 2022;43:230–44. https://doi.org/10.1016/j.it.2022.01.007.Search in Google Scholar PubMed PubMed Central

153. Werenberg Dreier, J, Nybo Andersen, AM, Hvolby, A, Garne, E, Kragh Andersen, P, Berg-Beckhoff, G. Fever and infections in pregnancy and risk of attention deficit/hyperactivity disorder in the offspring. J Child Psychol Psychiatry Allied Discip 2016;57:540–8. https://doi.org/10.1111/jcpp.12480.Search in Google Scholar PubMed

154. Dunn, GA, Nigg, JT, Sullivan, EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacology Biochem Behav 2019;182:22–34. https://doi.org/10.1016/j.pbb.2019.05.005.Search in Google Scholar PubMed PubMed Central

155. Ginsberg, Y, D’Onofrio, BM, Rickert, ME, Class, QA, Rosenqvist, MA, Almqvist, C, et al.. Maternal infection requiring hospitalization during pregnancy and attention-deficit hyperactivity disorder in offspring: a quasi-experimental family-based study. J Child Psychol Psychiatry Allied Discip 2019;60:160–8. https://doi.org/10.1111/jcpp.12959.Search in Google Scholar PubMed

156. Ellman, LM, Yolken, RH, Buka, SL, Torrey, EF, Cannon, TD. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatr 2009;65:1040–7. https://doi.org/10.1016/j.biopsych.2008.12.015.Search in Google Scholar PubMed PubMed Central

157. Brown, AS, Vinogradov, S, Kremen, WS, Poole, JH, Bao, Y, Kern, D, et al.. Association of maternal genital and reproductive infections with verbal memory and motor deficits in adult schizophrenia. Psychiatr Res 2011;188:179–86. https://doi.org/10.1016/j.psychres.2011.04.020.Search in Google Scholar PubMed PubMed Central

158. Thangarajan, R, Tantradi, RR, Rai, KS, Gopalakrishnan, S, Perumal, V. Inflammation during gestation induced spatial memory and learning deficits: attenuated by physical exercise in juvenile rats. J Clin Diagn Res 2015;9:Cf01–4. https://doi.org/10.7860/jcdr/2015/12565.6020.Search in Google Scholar

159. Mednick, SA, Machon, RA, Huttunen, MO, Bonett, D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatr 1988;45:189–92. https://doi.org/10.1001/archpsyc.1988.01800260109013.Search in Google Scholar PubMed

160. Brown, AS, Begg, MD, Gravenstein, S, Schaefer, CA, Wyatt, RJ, Bresnahan, M, et al.. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatr 2004;61:774–80. https://doi.org/10.1001/archpsyc.61.8.774.Search in Google Scholar PubMed

161. Brown, AS, Hooton, J, Schaefer, CA, Zhang, H, Petkova, E, Babulas, V, et al.. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatr 2004;161:889–95. https://doi.org/10.1176/appi.ajp.161.5.889.Search in Google Scholar PubMed

162. Watson, CG, Kucala, T, Tilleskjor, C, Jacobs, L. Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch Gen Psychiatr 1984;41:85–90. https://doi.org/10.1001/archpsyc.1984.01790120089011.Search in Google Scholar PubMed

163. O’Callaghan, E, Sham, PC, Takei, N, Murray, G, Glover, G, Hare, EH, et al.. The relationship of schizophrenic births to 16 infectious diseases. Br J Psychiatry 1994;165:353–6. https://doi.org/10.1192/bjp.165.3.353.Search in Google Scholar PubMed

164. Brown, AS, Cohen, P, Harkavy-Friedman, J, Babulas, V, Malaspina, D, Gorman, JM, et al.. A.E. Bennett research award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatr 2001;49:473–86. https://doi.org/10.1016/s0006-3223(01)01068-x.Search in Google Scholar PubMed

165. Fatemi, SH, Earle, J, Kanodia, R, Kist, D, Emamian, ES, Patterson, PH, et al.. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002;22:25–33. https://doi.org/10.1023/a:1015337611258.10.1023/A:1015337611258Search in Google Scholar PubMed

166. Gordon-Lipkin, E, Hoon, A, Pardo, CA. Prenatal cytomegalovirus, rubella, and Zika virus infections associated with developmental disabilities: past, present, and future. Dev Med Child Neurol 2021;63:135–43. https://doi.org/10.1111/dmcn.14682.Search in Google Scholar PubMed PubMed Central

167. Dammann, O, Kuban, KC, Leviton, A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment Retard Dev Disabil Res Rev 2002;8:46–50. https://doi.org/10.1002/mrdd.10005.Search in Google Scholar PubMed

168. Elovitz, MA, Mrinalini, C, Sammel, MD. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr Res 2006;59:50–5. https://doi.org/10.1203/01.pdr.0000191141.21932.b6.Search in Google Scholar PubMed

169. Burd, I, Chai, J, Gonzalez, J, Ofori, E, Monnerie, H, Le Roux, PD, et al.. Beyond white matter damage: fetal neuronal injury in a mouse model of preterm birth. Am J Obstet Gynecol 2009;201:279.e1–8. https://doi.org/10.1016/j.ajog.2009.06.013.Search in Google Scholar PubMed PubMed Central

170. Patterson, PH. Maternal infection and immune involvement in autism. Trends Mol Med 2011;17:389–94. https://doi.org/10.1016/j.molmed.2011.03.001.Search in Google Scholar PubMed PubMed Central

171. Elovitz, MA, Brown, AG, Breen, K, Anton, L, Maubert, M, Burd, I. Intrauterine inflammation, insufficient to induce parturition, still evokes fetal and neonatal brain injury. Int J Dev Neurosci 2011;29:663–71. https://doi.org/10.1016/j.ijdevneu.2011.02.011.Search in Google Scholar PubMed PubMed Central

172. Meyer, U. Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. Biol Psychiatr 2014;75:307–15. https://doi.org/10.1016/j.biopsych.2013.07.011.Search in Google Scholar PubMed

173. Yim, YS, Park, A, Berrios, J, Lafourcade, M, Pascual, LM, Soares, N, et al.. Reversing behavioural abnormalities in mice exposed to maternal inflammation. Nature 2017;549:482–7. https://doi.org/10.1038/nature23909.Search in Google Scholar PubMed PubMed Central

174. Cai, Z, Pan, ZL, Pang, Y, Evans, OB, Rhodes, PG. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 2000;47:64–72. https://doi.org/10.1203/00006450-200001000-00013.Search in Google Scholar PubMed

175. Zuckerman, L, Weiner, I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005;39:311–23. https://doi.org/10.1016/j.jpsychires.2004.08.008.Search in Google Scholar PubMed

176. Dalsgaard, S, Waltoft, BL, Leckman, JF, Mortensen, PB. Maternal history of autoimmune disease and later development of tourette syndrome in offspring. J Am Acad Child Adolesc Psychiatry 2015;54:495–501.e1. https://doi.org/10.1016/j.jaac.2015.03.008.Search in Google Scholar PubMed

177. Chen, SW, Zhong, XS, Jiang, LN, Zheng, XY, Xiong, YQ, Ma, SJ, et al.. Maternal autoimmune diseases and the risk of autism spectrum disorders in offspring: a systematic review and meta-analysis. Behav Brain Res 2016;296:61–9. https://doi.org/10.1016/j.bbr.2015.08.035.Search in Google Scholar PubMed

178. Instanes, JT, Halmøy, A, Engeland, A, Haavik, J, Furu, K, Klungsøyr, K. Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biol Psychiatr 2017;81:452–9. https://doi.org/10.1016/j.biopsych.2015.11.024.Search in Google Scholar PubMed

179. Mataix-Cols, D, Frans, E, Pérez-Vigil, A, Kuja-Halkola, R, Gromark, C, Isomura, K, et al.. A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette’s/chronic tic disorders. Mol Psychiatr 2018;23:1652–8. https://doi.org/10.1038/mp.2017.215.Search in Google Scholar PubMed PubMed Central

180. Zhao, L, Li, X, Liu, G, Han, B, Wang, J, Jiang, X. The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis. Neuropsychiatric Dis Treat 2019;15:675–84. https://doi.org/10.2147/ndt.s189200.Search in Google Scholar PubMed PubMed Central

181. Zeng, Y, Tang, Y, Yue, Y, Li, W, Qiu, X, Hu, P, et al.. Cumulative evidence for association of parental diabetes mellitus and attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev 2020;117:129–39. https://doi.org/10.1016/j.neubiorev.2019.11.003.Search in Google Scholar PubMed

182. Nielsen, TC, Nassar, N, Shand, AW, Jones, H, Guastella, AJ, Dale, RC, et al.. Association of maternal autoimmune disease with attention-deficit/hyperactivity disorder in children. JAMA Pediatr 2021;175:e205487. https://doi.org/10.1001/jamapediatrics.2020.5487.Search in Google Scholar PubMed PubMed Central

183. Croen, LA, Grether, JK, Yoshida, CK, Odouli, R, Van de Water, J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 2005;159:151–7. https://doi.org/10.1001/archpedi.159.2.151.Search in Google Scholar PubMed

184. Gong, T, Lundholm, C, Rejnö, G, Bölte, S, Larsson, H, D’Onofrio, BM, et al.. Parental asthma and risk of autism spectrum disorder in offspring: a population and family-based case-control study. Clin Exp Allergy 2019;49:883–91. https://doi.org/10.1111/cea.13353.Search in Google Scholar PubMed PubMed Central

185. Liu, X, Dalsgaard, S, Munk-Olsen, T, Li, J, Wright, RJ, Momen, NC. Parental asthma occurrence, exacerbations and risk of attention-deficit/hyperactivity disorder. Brain Behav Immun 2019;82:302–8. https://doi.org/10.1016/j.bbi.2019.08.198.Search in Google Scholar PubMed PubMed Central

186. Jenabi, E, Bashirian, S, Khazaei, S, Basiri, Z. The maternal prepregnancy body mass index and the risk of attention deficit hyperactivity disorder among children and adolescents: a systematic review and meta-analysis. Korean J Pediatr 2019;62:374–9. https://doi.org/10.3345/kjp.2019.00185.Search in Google Scholar PubMed PubMed Central

187. Ponzio, NM, Servatius, R, Beck, K, Marzouk, A, Kreider, T. Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring. Ann N Y Acad Sci 2007;1107:118–28. https://doi.org/10.1196/annals.1381.013.Search in Google Scholar PubMed

188. Choi, GB, Yim, YS, Wong, H, Kim, S, Kim, H, Kim, SV, et al.. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 2016;351:933–9. https://doi.org/10.1126/science.aad0314.Search in Google Scholar PubMed PubMed Central

189. Krakowiak, P, Goines, PE, Tancredi, DJ, Ashwood, P, Hansen, RL, Hertz-Picciotto, I, et al.. Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatr 2017;81:442–51. https://doi.org/10.1016/j.biopsych.2015.08.007.Search in Google Scholar PubMed PubMed Central

190. Smith, SE, Li, J, Garbett, K, Mirnics, K, Patterson, PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007;27:10695–702. https://doi.org/10.1523/jneurosci.2178-07.2007.Search in Google Scholar

191. Buka, SL, Tsuang, MT, Torrey, EF, Klebanoff, MA, Wagner, RL, Yolken, RH. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001;15:411–20. https://doi.org/10.1006/brbi.2001.0644.Search in Google Scholar PubMed

192. Boksa, P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010;24:881–97. https://doi.org/10.1016/j.bbi.2010.03.005.Search in Google Scholar PubMed

193. Abdallah, MW, Larsen, N, Mortensen, EL, Atladóttir, H, Nørgaard-Pedersen, B, Bonefeld-Jørgensen, EC, et al.. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the danish newborn screening biobank. J Neuroimmunol 2012;252:75–82. https://doi.org/10.1016/j.jneuroim.2012.07.013.Search in Google Scholar PubMed

194. Abdallah, MW, Larsen, N, Grove, J, Bonefeld-Jørgensen, EC, Nørgaard-Pedersen, B, Hougaard, DM, et al.. Neonatal chemokine levels and risk of autism spectrum disorders: findings from a Danish historic birth cohort follow-up study. Cytokine 2013;61:370–6. https://doi.org/10.1016/j.cyto.2012.11.015.Search in Google Scholar PubMed

195. Zerbo, O, Yoshida, C, Grether, JK, Van de Water, J, Ashwood, P, Delorenze, GN, et al.. Neonatal cytokines and chemokines and risk of autism spectrum disorder: the early markers for autism (EMA) study: a case-control study. J Neuroinflammation 2014;11:113. https://doi.org/10.1186/1742-2094-11-113.Search in Google Scholar PubMed PubMed Central

196. Jones, KL, Croen, LA, Yoshida, CK, Heuer, L, Hansen, R, Zerbo, O, et al.. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatr 2017;22:273–9. https://doi.org/10.1038/mp.2016.77.Search in Google Scholar PubMed PubMed Central

197. Kirsten, TB, Casarin, RC, Bernardi, MM, Felicio, LF. Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway. PLoS One 2018;13:e0197060. https://doi.org/10.1371/journal.pone.0197060.Search in Google Scholar PubMed PubMed Central

198. Heuer, LS, Croen, LA, Jones, KL, Yoshida, CK, Hansen, RL, Yolken, R, et al.. An exploratory examination of neonatal cytokines and chemokines as predictors of autism risk: the early markers for autism study. Biol Psychiatr 2019;86:255–64. https://doi.org/10.1016/j.biopsych.2019.04.037.Search in Google Scholar PubMed PubMed Central

199. Spann, MN, Monk, C, Scheinost, D, Peterson, BS. Maternal immune activation during the third trimester is associated with neonatal functional connectivity of the salience network and fetal to toddler behavior. J Neurosci 2018;38:2877–86. https://doi.org/10.1523/jneurosci.2272-17.2018.Search in Google Scholar

200. Rudolph, MD, Graham, AM, Feczko, E, Miranda-Dominguez, O, Rasmussen, JM, Nardos, R, et al.. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat Neurosci 2018;21:765–72. https://doi.org/10.1038/s41593-018-0128-y.Search in Google Scholar PubMed PubMed Central

201. Graham, AM, Rasmussen, JM, Rudolph, MD, Heim, CM, Gilmore, JH, Styner, M, et al.. Maternal systemic interleukin-6 during pregnancy is associated with newborn amygdala phenotypes and subsequent behavior at 2 Years of age. Biol Psychiatr 2018;83:109–19. https://doi.org/10.1016/j.biopsych.2017.05.027.Search in Google Scholar PubMed PubMed Central

202. Rasmussen, JM, Graham, AM, Entringer, S, Gilmore, JH, Styner, M, Fair, DA, et al.. Maternal Interleukin-6 concentration during pregnancy is associated with variation in frontolimbic white matter and cognitive development in early life. Neuroimage 2019;185:825–35. https://doi.org/10.1016/j.neuroimage.2018.04.020.Search in Google Scholar PubMed PubMed Central

203. Chow, SS, Craig, ME, Jones, CA, Hall, B, Catteau, J, Lloyd, AR, et al.. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine 2008;44:78–84. https://doi.org/10.1016/j.cyto.2008.06.009.Search in Google Scholar PubMed

204. Abdallah, MW, Larsen, N, Grove, J, Nørgaard-Pedersen, B, Thorsen, P, Mortensen, EL, et al.. Amniotic fluid chemokines and autism spectrum disorders: an exploratory study utilizing a danish historic birth cohort. Brain Behav Immun 2012;26:170–6. https://doi.org/10.1016/j.bbi.2011.09.003.Search in Google Scholar PubMed

205. Abdallah, MW, Pearce, BD, Larsen, N, Greaves-Lord, K, Nørgaard-Pedersen, B, Hougaard, DM, et al.. Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study. Autism Res 2012;5:428–33. https://doi.org/10.1002/aur.1254.Search in Google Scholar PubMed

206. Dammann, O, Phillips, TM, Allred, EN, O’Shea, TM, Paneth, N, Van Marter, LJ, et al.. Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001;13:234–9. https://doi.org/10.1006/cyto.2000.0820.Search in Google Scholar PubMed

207. Leviton, A, Hecht, JL, Allred, EN, Yamamoto, H, Fichorova, RN, Dammann, O. Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Immunol 2011;90:235–43. https://doi.org/10.1016/j.jri.2011.03.009.Search in Google Scholar PubMed

208. Leviton, A, Joseph, RM, Fichorova, RN, Allred, EN, Gerry Taylor, H, Michael O’Shea, T, et al.. Executive dysfunction early postnatal biomarkers among children born extremely preterm. J Neuroimmune Pharmacol 2019;14:188–99. https://doi.org/10.1007/s11481-018-9804-7.Search in Google Scholar PubMed PubMed Central

209. Lu, H, Huang, W, Chen, X, Wang, Q, Zhang, Q, Chang, M. Relationship between premature brain injury and multiple biomarkers in cord blood and amniotic fluid. J Matern Fetal Neonatal Med 2018;31:2898–904. https://doi.org/10.1080/14767058.2017.1359532.Search in Google Scholar PubMed

210. Gayle, DA, Beloosesky, R, Desai, M, Amidi, F, Nuñez, SE, Ross, MG. Maternal LPS induces cytokines in the amniotic fluid and corticotropin releasing hormone in the fetal rat brain. Am J Physiol Regul Integr Comp Physiol 2004;286:R1024–9. https://doi.org/10.1152/ajpregu.00664.2003.Search in Google Scholar PubMed

211. Reicher, L, Dabaja, H, Ginsberg, Y, Khatib, N, Fouks, Y, Attali, E, et al.. Fetal neuroprotective mechanism of maternal magnesium sulfate: proteomic analysis. J Mol Neurosci 2022;72:626–32. https://doi.org/10.1007/s12031-021-01939-y.Search in Google Scholar PubMed

212. Brown, AG, Tulina, NM, Barila, GO, Hester, MS, Elovitz, MA. Exposure to intrauterine inflammation alters metabolomic profiles in the amniotic fluid, fetal and neonatal brain in the mouse. PLoS One 2017;12:e0186656. https://doi.org/10.1371/journal.pone.0186656.Search in Google Scholar PubMed PubMed Central

213. Beloosesky, R, Gayle, DA, Amidi, F, Nunez, SE, Babu, J, Desai, M, et al.. N-acetyl-cysteine suppresses amniotic fluid and placenta inflammatory cytokine responses to lipopolysaccharide in rats. Am J Obstet Gynecol 2006;194:268–73. https://doi.org/10.1016/j.ajog.2005.06.082.Search in Google Scholar PubMed

214. Awad, N, Khatib, N, Ginsberg, Y, Weiner, Z, Maravi, N, Thaler, I, et al.. N-acetyl-cysteine (NAC) attenuates LPS-induced maternal and amniotic fluid oxidative stress and inflammatory responses in the preterm gestation. Am J Obstet Gynecol 2011;204:450.e15–20. https://doi.org/10.1016/j.ajog.2011.01.030.Search in Google Scholar PubMed

215. Beloosesky, R, Weiner, Z, Khativ, N, Maravi, N, Mandel, R, Boles, J, et al.. Prophylactic maternal n-acetylcysteine before lipopolysaccharide suppresses fetal inflammatory cytokine responses. Am J Obstet Gynecol 2009;200:665.e1–5. https://doi.org/10.1016/j.ajog.2009.01.032.Search in Google Scholar PubMed

216. Beloosesky, R, Gayle, DA, Ross, MG. Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide. Am J Obstet Gynecol 2006;195:1053–7. https://doi.org/10.1016/j.ajog.2006.06.081.Search in Google Scholar PubMed

217. Beloosesky, R, Weiner, Z, Ginsberg, Y, Ross, MG. Maternal N-acetyl-cysteine (NAC) protects the rat fetal brain from inflammatory cytokine responses to lipopolysaccharide (LPS). J Matern Fetal Neonatal Med 2012;25:1324–8. https://doi.org/10.3109/14767058.2011.632793.Search in Google Scholar PubMed

218. Tam Tam, HB, Dowling, O, Xue, X, Lewis, D, Rochelson, B, Metz, CN. Magnesium sulfate ameliorates maternal and fetal inflammation in a rat model of maternal infection. Am J Obstet Gynecol 2011;204:364.e1–8. https://doi.org/10.1016/j.ajog.2010.11.006.Search in Google Scholar PubMed

219. Khatib, N, Ginsberg, Y, Shalom-Paz, E, Dabaja, H, Gutzeit, O, Zmora, O, et al.. Fetal neuroprotective mechanism of maternal magnesium sulfate for late gestation inflammation: in a rodent model. J Matern Fetal Neonatal Med 2020;33:3732–9. https://doi.org/10.1080/14767058.2019.1583735.Search in Google Scholar PubMed

220. Carty, ML, Wixey, JA, Colditz, PB, Buller, KM. Post-insult minocycline treatment attenuates hypoxia-ischemia-induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens. Int J Dev Neurosci 2008;26:477–85. https://doi.org/10.1016/j.ijdevneu.2008.02.005.Search in Google Scholar PubMed

221. Tang, J, Chen, Q, Guo, J, Yang, L, Tao, Y, Li, L, et al.. Minocycline attenuates neonatal germinal-matrix-hemorrhage-induced neuroinflammation and brain edema by activating cannabinoid receptor 2. Mol Neurobiol 2016;53:1935–48. https://doi.org/10.1007/s12035-015-9154-x.Search in Google Scholar PubMed

222. Giovanoli, S, Engler, H, Engler, A, Richetto, J, Feldon, J, Riva, MA, et al.. Preventive effects of minocycline in a neurodevelopmental two-hit model with relevance to schizophrenia. Transl Psychiatry 2016;6:e772. https://doi.org/10.1038/tp.2016.38.Search in Google Scholar PubMed PubMed Central

223. Fan, LW, Kaizaki, A, Tien, LT, Pang, Y, Tanaka, S, Numazawa, S, et al.. Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats. Neuroscience 2013;240:27–38. https://doi.org/10.1016/j.neuroscience.2013.02.041.Search in Google Scholar PubMed PubMed Central

224. Kaizaki, A, Tien, LT, Pang, Y, Cai, Z, Tanaka, S, Numazawa, S, et al.. Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharide. J Neuroinflammation 2013;10:45. https://doi.org/10.1186/1742-2094-10-45.Search in Google Scholar PubMed PubMed Central

225. Kannan, S, Dai, H, Navath, RS, Balakrishnan, B, Jyoti, A, Janisse, J, et al.. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Sci Transl Med 2012;4:130ra46. https://doi.org/10.1126/scitranslmed.3003162.Search in Google Scholar PubMed PubMed Central

226. Allan, NP, Hume, LE, Allan, DM, Farrington, AL, Lonigan, CJ. Relations between inhibitory control and the development of academic skills in preschool and kindergarten: a meta-analysis. Dev Psychol 2014;50:2368–79. https://doi.org/10.1037/a0037493.Search in Google Scholar PubMed

227. Moffitt, TE, Arseneault, L, Belsky, D, Dickson, N, Hancox, RJ, Harrington, H, et al.. A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci U S A 2011;108:2693–8. https://doi.org/10.1073/pnas.1010076108.Search in Google Scholar PubMed PubMed Central

228. Blair, C, Razza, RP. Relating effortful control, executive function, and false belief understanding to emerging math and literacy ability in kindergarten. Child Dev 2007;78:647–63. https://doi.org/10.1111/j.1467-8624.2007.01019.x.Search in Google Scholar PubMed

229. Mischel, W, Shoda, Y, Rodriguez, MI. Delay of gratification in children. Science 1989;244:933–8. https://doi.org/10.1126/science.2658056.Search in Google Scholar PubMed

230. O’Hearn, K, Asato, M, Ordaz, S, Luna, B. Neurodevelopment and executive function in autism. Dev Psychopathol 2008;20:1103–32. https://doi.org/10.1017/s0954579408000527.Search in Google Scholar PubMed

231. Pietrefesa, AS, Evans, DW. Affective and neuropsychological correlates of children’s rituals and compulsive-like behaviors: continuities and discontinuities with obsessive-compulsive disorder. Brain Cognit 2007;65:36–46. https://doi.org/10.1016/j.bandc.2006.02.007.Search in Google Scholar PubMed

232. Castellanos, FX, Sonuga-Barke, EJ, Milham, MP, Tannock, R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cognit Sci 2006;10:117–23. https://doi.org/10.1016/j.tics.2006.01.011.Search in Google Scholar PubMed

233. Ameis, SH, Catani, M. Altered white matter connectivity as a neural substrate for social impairment in autism spectrum disorder. Cortex 2015;62:158–81. https://doi.org/10.1016/j.cortex.2014.10.014.Search in Google Scholar PubMed

234. Bettcher, BM, Mungas, D, Patel, N, Elofson, J, Dutt, S, Wynn, M, et al.. Neuroanatomical substrates of executive functions: beyond prefrontal structures. Neuropsychologia 2016;85:100–9. https://doi.org/10.1016/j.neuropsychologia.2016.03.001.Search in Google Scholar PubMed PubMed Central

235. Wang, Y, Metoki, A, Alm, KH, Olson, IR. White matter pathways and social cognition. Neurosci Biobehav Rev 2018;90:350–70. https://doi.org/10.1016/j.neubiorev.2018.04.015.Search in Google Scholar PubMed PubMed Central

236. Bells, S, Lefebvre, J, Prescott, SA, Dockstader, C, Bouffet, E, Skocic, J, et al.. Changes in white matter microstructure impact cognition by disrupting the ability of neural assemblies to synchronize. J Neurosci 2017;37:8227–38. https://doi.org/10.1523/jneurosci.0560-17.2017.Search in Google Scholar PubMed PubMed Central

237. Cainelli, E, Arrigoni, F, Vedovelli, L. White matter injury and neurodevelopmental disabilities: a cross-disease (dis)connection. Prog Neurobiol 2020;193:101845. https://doi.org/10.1016/j.pneurobio.2020.101845.Search in Google Scholar PubMed

238. Romero, R, Miranda, J, Chaiworapongsa, T, Korzeniewski, SJ, Chaemsaithong, P, Gotsch, F, et al.. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Repord Immunol 2014;72:458–74. https://doi.org/10.1111/aji.122965.Search in Google Scholar PubMed PubMed Central

239. Yoon, BH, Romero, R, Park, JY, Oh, KJ, Lee, J, Conde-Agudelo, A, et al.. Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes. Am J Obstet Gynecol 2019;221:142.e1–22. https://doi.org/10.1016/j.ajog.2019.03.018.Search in Google Scholar PubMed PubMed Central

240. Kacerovsky, M, Romero, R, Stepan, M, Stranik, J, Maly, J, Pliskova, L, et al.. Antibiotic administration reduces the rate of intraamniotic inflammation in preterm prelabor rupture of the membranes. Am J Obstet Gynecol 2020;223. https://doi.org/10.1016/j.ajog.2020.01.043.Search in Google Scholar PubMed PubMed Central

Received: 2022-05-26
Accepted: 2022-07-17
Published Online: 2022-09-29
Published in Print: 2023-03-28

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. A Celebration of Professor Joachim Dudenhausen
  4. Reviews
  5. Gestational complications associated with SARS-CoV-2 infection in pregnant women during 2020–2021: systematic review of longitudinal studies
  6. Eclampsia a preventable tragedy: an African overview
  7. Original Articles – Obstetrics
  8. How do bicornuate uteri alter pregnancy, intra-partum and neonatal risks? A population based study of more than three million deliveries and more than 6000 bicornuate uteri
  9. Maternal urogenital infection and fetal heart functional assessment – what is the missing link?
  10. Knowledge and attitudes of pregnant women on maternal immunization against COVID-19 in Croatia
  11. Retrospective review of GCT cutoff value based on pre-pregnancy BMI class in patients with GDM
  12. Cervical strain elastography: pattern analysis and cervical sliding sign in preterm and control pregnancies
  13. Maternal race/ethnicity impacts the success rates of external cephalic version (ECV) in the United States
  14. Fetal adrenal gland size and umbilical artery Doppler in growth-restricted fetuses
  15. Counseling pregnant women on calcium: effects on calcium intake
  16. Relationship among anogenital distance, adrenal gland volume, and penile length and width at 22–36 weeks of pregnancy
  17. Intra-amniotic inflammation in the mid-trimester of pregnancy is a risk factor for neuropsychological disorders in childhood
  18. Genetic amniocentesis using atraumatic 29 gauge needle in patients having a chorioamniotic separation
  19. YouTube as a source of patient information on external cephalic version
  20. Midwives’ personal and professional attitudes towards women’s delivery choices, interventions and neonatal care
  21. Maternal serum midkine level in fetal growth restriction: a case-control study
  22. Original Articles – Neonates
  23. Interventions for reducing late-onset sepsis in neonates: an umbrella review
  24. Maternal knowledge of recommendations for safe infant sleep and intentions for implementation – a cross sectional analysis of data from the KUNO-Kids birth cohort study
  25. Short Communication
  26. Lysophosphatidylcholine acyltransferase 1 protein is present in maternal blood in the third trimester and is upregulated by antenatal corticosteroids
  27. Letters to the Editor
  28. Peripartum hysterectomy at a tertiary university perinatal center – retrospective analysis of the 25-year period
  29. Neonate, infected mother and monkeypox: the present concern
https://doi.org/10.1515/jpm-2022-0255
Keywords for this article
amniocentesis; amniotic fluid; behavioral testing; C-X-C motif chemokine ligand 10 (CXCL-10); cognitive testing; cytokine; infection; interferon-γ-inducible protein 10 (IP-10); interleukin 6 (IL-6); neurodevelopment; neuroinflammatory

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. A Celebration of Professor Joachim Dudenhausen
  4. Reviews
  5. Gestational complications associated with SARS-CoV-2 infection in pregnant women during 2020–2021: systematic review of longitudinal studies
  6. Eclampsia a preventable tragedy: an African overview
  7. Original Articles – Obstetrics
  8. How do bicornuate uteri alter pregnancy, intra-partum and neonatal risks? A population based study of more than three million deliveries and more than 6000 bicornuate uteri
  9. Maternal urogenital infection and fetal heart functional assessment – what is the missing link?
  10. Knowledge and attitudes of pregnant women on maternal immunization against COVID-19 in Croatia
  11. Retrospective review of GCT cutoff value based on pre-pregnancy BMI class in patients with GDM
  12. Cervical strain elastography: pattern analysis and cervical sliding sign in preterm and control pregnancies
  13. Maternal race/ethnicity impacts the success rates of external cephalic version (ECV) in the United States
  14. Fetal adrenal gland size and umbilical artery Doppler in growth-restricted fetuses
  15. Counseling pregnant women on calcium: effects on calcium intake
  16. Relationship among anogenital distance, adrenal gland volume, and penile length and width at 22–36 weeks of pregnancy
  17. Intra-amniotic inflammation in the mid-trimester of pregnancy is a risk factor for neuropsychological disorders in childhood
  18. Genetic amniocentesis using atraumatic 29 gauge needle in patients having a chorioamniotic separation
  19. YouTube as a source of patient information on external cephalic version
  20. Midwives’ personal and professional attitudes towards women’s delivery choices, interventions and neonatal care
  21. Maternal serum midkine level in fetal growth restriction: a case-control study
  22. Original Articles – Neonates
  23. Interventions for reducing late-onset sepsis in neonates: an umbrella review
  24. Maternal knowledge of recommendations for safe infant sleep and intentions for implementation – a cross sectional analysis of data from the KUNO-Kids birth cohort study
  25. Short Communication
  26. Lysophosphatidylcholine acyltransferase 1 protein is present in maternal blood in the third trimester and is upregulated by antenatal corticosteroids
  27. Letters to the Editor
  28. Peripartum hysterectomy at a tertiary university perinatal center – retrospective analysis of the 25-year period
  29. Neonate, infected mother and monkeypox: the present concern
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 26.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpm-2022-0255/html
Scroll to top button